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SUMMARY 
miRNAs cooperate and fine tune gene expression on the post-transcriptional level and 
can therefore be seen as an additional regulatory layer during mouse embryonic stem cell 
(mESC) self-renewal and differentiation. However, the biological activity of conserved 
miRNAs during those processes is poorly understood, as most studies cannot uncouple 
miRNA activity from miRNA expression levels. Therefore, my PhD project focused on 
studying single cell miRNA dynamics during mESC differentiation towards the three 
major germ layers and measured miRNA affinities to a miRNA reporter in vivo. I 
established stable mESC lines expressing fluorescent reporters for the 162 miRNAs 
conserved in vertebrates and could show that the temporal miRNA activity profile is 
tightly regulated throughout mESC differentiation. Interestingly, miRNAs exhibit 
activity changes at early, mid and late stages of stem cell differentiation. Moreover, 
miRNAs seem to regulate differentiation in a cooperative manner on a global level rather 
than being germ layer specific. However, this does not exclude single miRNA clusters 
from being potentially germ layer specific as shown for the highly conserved miR-302 
cluster. Strikingly, based on principle component analysis, miRNA activity diverged 
between germ layer fates already 48 hours after onset of differentiation. 
In addition, this PhD project experimentally determined miRNA affinities for 119 
conserved miRNAs by integrating measurements of miRNA activity and expression 
levels. I could show that miRNA affinities span several orders of magnitude and are 
negatively correlated to miRNA expression levels, which suggests that weakly expressed 
miRNAs can be as potent as highly expressed ones. Knowing the affinity and expression 
levels in a given cell type, enabled me to rank miRNAs according to their effective 
potency. This will potentially help to determine which genes are targets of a given 
miRNA.  
In summary, this thesis project provides a comprehensive picture of changes in 
miRNA activity upon mESC differentiation in addition to experimentally determined 
miRNA affinities. Future gain and loss-of-function experiments of interesting miRNAs 
in fluorescently labeled fate marker cell lines will potentially reveal miRNAs 
indispensable for stem cell differentiation. 
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ZUSAMMENFASSUNG 
microRNAs (miRNAs) spielen eine wichtige Rolle bei der Koordination und 
Feinjustierung der Genexpression auf post-transkriptionaler Ebene. Daher werden sie als 
zusätzlich regulatorische Ebene bei der Erneuerung und Differenzierung embryonaler 
Stammzellen betrachtet. Die biologische Aktivität evolutionär konservierter miRNAs ist 
jedoch unzureichend erforscht, da die meisten Studien nicht zwischen miRNA 
Genexpression und biologischer Aktivität unterscheiden. Daher liegt der Focus meiner 
Doktorarbeit auf der Untersuchung von miRNA Affinitäten und Dynamiken während der 
Erneuerung und Differenzierung von embryonalen Stammzellen in die drei 
Hauptkeimblätter Mesoderm, Endoderm und Ectoderm. Dazu habe ich 162 miRNA 
Sensor Ziellinien entwickelt, die spezifisch die Affinität zu einem fluoreszierenden 
Sensor sowie dessen biologische Aktivität messen. Der daraus resultierende Datensatz 
umfasst alle evolutionär konservierten miRNAs in Wirbeltieren.  
Diese Daten zeigen, dass die Aktivität der miRNAs während der Differenzierung 
zeitlich sehr strikt geregelt ist. Aktivitätsänderungen sind dabei zu frühen, mittleren und 
späten Zeitpunkten der Stammzelldifferenzierung zu beobachten. Zudem scheinen 
miRNAs auf globaler Ebene zu kooperieren, statt Keimblatt spezifisch zu wirken. Dies 
schließt keineswegs die Funktionalität keimblattspezischer miRNA cluster aus, wie am 
Beispiel des miR-302 clusters gezeigt werden konnte. Die Hauptkomponentenanalyse 
(PCA) des miRNA Aktivitätsdatensatzes hat zudem ergeben, dass sich die drei 
Hauptkeimblätter bereits 48 Stunden nach Differenzierungsbeginn unterscheiden. 
Ferner wird in dieser Doktorarbeit die Affinität von 119 evolutionär konservierten 
miRNAs experimentell bestimmt. Interessanterweise, variieren die Affinitäten über 
mehrere Größenordnungen und korrelieren zudem negativ mit der miRNA Menge. Daher 
können gering exprimierte miRNAs die gleiche oder eine stärkere Wirkung erzielen wie 
stark exprimierte miRNAs. Die Bestimmung von miRNA Expressionsmengen und 
miRNA Affinitäten ermöglichte eine Klassifizierung nach ihrer Wirkungsstärke. Eine 
solche Klassifizierung kann dazu beitragen, miRNA Kandidaten mit besonders hoher 
biologischer Relevanz zu identifizieren und in weiteren Studien deren target mRNAs 
sowie regulierter Signalwege zu bestimmen. 
Das vorliegende Projekt gibt einen umfassenden Einblick in die dynamischen 
Aktivitätsänderungen von miRNAs während der Stammzelldifferenzierung und 
  xii 
beschreibt die experimentelle Bestimmung von bisher vernachlässigten miRNA 
Affinitäten. Zukünftige „gain and loss-of-function“ Experimente von vielversprechenden 
miRNA Kandidaten in fluoreszierenden „fate-marker“ Zellinien werden dazu beitragen, 
die für die Stammzelldifferenzierung essentiellen miRNAs zu identifizieren. Diese 
Erkenntnisse werden besonders für die regenerative Medizin von großem Nutzen sein. 
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1  INTRODUCTION 
1.1  Embryonic stem cells as model system 
Stem cells comprise the ability to self-renew and differentiate towards specialized cell 
types. Yet, their developmental potency varies considerably (De Los Angeles et al. 2015). 
A totipotent zygote, has the capacity to give rise to all embryonic and extraembryonic 
tissue (Nichols and Smith 2012). Moreover, zygotes are programmed to undergo a 
defined process of cleavage divisions which results in loss of pluripotency as the embryo 
develops (Niakan et al. 2012). This characteristic makes it challenging to study molecular 
basics of pluripotency in vivo, however, their developmental potential has not been 
captured in vitro. Therefore, blastocyst derived embryonic stem cells (ESCs) are used to 
study pluripotency and transient pluripotent cell populations in vivo (Evans and Kaufman 
1981; Martin et al. 1981; Nichols and Smith 2012).  
 
 
Figure 1: Pluripotent stem cells as model system. 
Pluripotent stem cells are derived from the inner cell mas and can be kept indefinitely in 
culture. They have the capacity to self-renew and can differentiate towards any specialized 
tissue of an organism. In addition to disease modeling and drug discovery, pluripotent stem 
cells are used as model system in developmental biology and regenerative medicine, in order 
to delineate the molecular circuitries of pluripotency and fate choice. Adapted from Hu 
(2018). 
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Compared to zygotes, ESCs are developmentally more restricted as they do not 
contribute to extraembryonic tissues like the placenta (Condic 2014), they still comprise 
the potency to differentiate into all tissues of an organism. ESCs can be maintained in 
vitro for extended periods of time, without loss of their capacity to contribute to any germ 
layer of the developing embryo (Lanza and Atala 2014). Therefore, ESCs possess great 
potential for applications in regenerative medicine, disease modeling and developmental 
biology (Figure 1) (Loh et al. 2006). Moreover, they are the model system of choice to 
study the molecular circuitry of pluripotent state (Jaenisch and Young 2008) and cell fate 
choice (Yamanaka and Ralston 2010).  
 
1.1.1  Transient pluripotency during embryonic development 
Pre-implantation development of the mammalian embryo starts with fertilization of the 
oocyte and involves several distinct cellular events. The zygote is considered totipotent 
and gives rise to all embryonic and extraembryonic tissues (Chazaud and Yamanaka 
2016). After the first cleavage division, the 2-cell stage is followed by the embryonic 
genome activation (EGA). After this transition, development is exclusively controlled by 
the embryonic genome as the maternal gene products have been degraded and embryonic 
transcription is evident (Saitou et al. 2012). EGA is a global activation of genes necessary 
to establish the pre-implantation developmental program. The next key developmental 
event occurs at the 8-cell morula stage, where polarization and compaction take place 
(Cockburn and Rossant 2010). Subsequent differentiation of the blastomeres’ builds the 
inner cell mass (ICM) in addition to the trophectoderm (TE), which gives rise to the 
placenta. As the embryo develops into a hollow sphere known as blastocyst, the ICM 
differentiates into the epiblast (Epi) and primitive endoderm (PrE) (Figure 2) (Miguel et 
al. 2010). Generation of the first three lineages trophectoderm, epiblast and primitive 
endoderm, seem to be orchestrated by differences in cell-to-cell interaction, gene 
expression levels as well as the microenvironment of individual cells rather “than the 
active partitioning of maternal determinants” (Chazaud and Yamanaka 2016).  
ESCs are derived from the ICM at embryonic day 3.5 (E 3.5) whereas EpiSCs are 
derived at later timepoints (E 5.5 – E 6.5). Pluripotency of epiblast cells is transient and 
persists for only few days in the developing embryo (Nichols and Smith 2012), which 
makes it difficult to study the molecular circuitries of primed pluripotency in vitro. 
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Interestingly, ESCs are the ex vivo equivalent of the epiblast stage in the preimplantation 
blastocyst and share the same developmental potential, therefore, ESCs can be 
differentiated into the three major germ layers endoderm, mesoderm and neuroectoderm 
(Czechanski et al. 2014). 
 
 
Figure 2: Origin of mESCs and mEpiSCs.  
Fertilization of the oocyte forms a totipotent stem cell (zygote) with the capacity to derive all 
embryonic and extraembryonic tissue of an organism. The developmental potency thereafter 
declines as cells begin to specialize. After several rounds of cleavage divisions, the early 
blastocyst is formed. The inner cell mass (ICM) separates into pluripotent epiblast cells (Epi) 
and primitive endoderm (PrE). The resulting late blastocyst resembles the last stage of pre-
implantation development and consists of developmentally restricted cells (TE, Epi, PrE). 
Embryonic stem cells (ESCs) are derived from the ICM at embryonic day E3.5. Epiblast 
derived stem cells (EpiSCs) are derived at E5.5 – E6.5. The blastocyst further develops into 
egg cylinder to prepare for germ layer specification. 
 
1.1.2  Origin and definition of pluripotent states 
Pluripotency is maintained by an interplay of extracellular signaling and intracellular 
gene expression circuits which keeps embryonic stem cells in an undifferentiated and 
self-renewing state (Miguel et al. 2010). As ESCs are derived from the ICM of the pre-
implantation blastocyst, hallmarks of ex-vivo pluripotency should correspond to the 
properties of the preimplantation epiblast. This includes: i) teratoma and chimera 
formation with germline transmission, ii) unlimited self-renewal capacity and the 
potential to derive any somatic cell type, iii) expression of a specific set of genes 
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associated with pluripotency, iv) global DNA hypomethylation v) two functional X-
chromosomes, vi) low level of bivalent histone marks, vii) the capability of metabolism 
through oxidative phosphorylation as well as glycolysis and viii) the lack of lineage 
priming (De Los Angeles et al. 2015). 
Two pluripotent stem cell states can currently be stabilized in culture: naïve (or 
“ground state”) and primed (EpiSCs) pluripotency (Nichols and Smith 2009). Naïve stem 
cells are derived from the pre-implantation embryo, whereas primed stem cells are 
derived from the post-implantation embryo (Najm et al. 2011). Although both cell types 
differentiate in vitro towards the three major germ layers, naïve and primed cells are 
distinct in their origins, biological characteristics, gene expression profiles, 
developmental potential and signal pathways dependences (Brons et al. 2007; Evans and 
Kaufman 1981; Tesar et al. 2007).  
 
1.1.3  The naïve state (“ground state”) of pluripotency  
A complex circuit of transcription factors (TFs) in addition to epigenetic regulators holds 
ESCs in naïve pluripotent state, mostly by repression of lineage specific genes and 
activation of core pluripotency factors like Nanog, Oct4 and Sox2 (Thomson et al. 2011). 
Thus, transcription factors are the perfect proxy to determine pluripotent cell populations 
or mark the onset of differentiation (Hackett and Azim Surani 2014). In the advent of 
naïve pluripotency exit, levels of Nanog, Klf2 and Tfcp211 TFs decline earlier than Rex1 
(Kalkan et al. 2017). Therefore, cells expressing Rex1 always maintain self-renewal 
capacity. Hence, Rex1 is considered to be one of the “real” naïve pluripotency markers, 
as its downregulation marks the irreversible exit from the naïve state (Kalkan and Smith 
2014).  
Stem cells are kept in “ground state” pluripotency (Ying et al. 2008) using 2i/LIF 
or Serum/LIF media conditions. 2i/LIF media contains the two inhibitors PD and CHIR 
(2i) which repress the extracellular-signal-regulated protein kinase (MEK/ERK) and 
glycogen synthase kinase-3 (GSK3) pathways. This results in the inhibition of the FGF 
pathways and activation of Wnt signaling (Sim et al. 2017). Therefore, 2i artificially 
rewires gene expression programs necessary to keep stem cells in an pluripotent state, 
which is usually transient in the developing embryo (Weinberger et al. 2016).  
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Serum/LIF media on the other hand, which is chemically undefined due to its 
serum content. Fetal bovine serum (FBS) provides a wide variety of embryonic growth 
promoting factors such as macromolecular proteins, nutrients, hormones and attachment 
factors (Jayme and Blackman 1985; Jayme, Epstein, and Conrad 1988). In addition, it 
adds buffering capacity to the media and neutralizes toxic components. On a molecular 
level Serum/LIF media is characterized by constitutively active MEK/ERK and GSK3 
signaling (Graf et al. 2011). Although MEK/ERK drives necessary genes for proliferation 
(Zhang and Liu 2002) and GSK3 benefits the Wnt pathways needed for self-renewal 
(Singh et al. 2012), the ERK pathway is also activated and known to facilitate 
differentiation (Tee et al. 2014) which in turn might antagonize pluripotency. Moreover, 
serum is thought to be the underlying component for heterogeneity in mESCs which was 
shown to be absent when cells are cultured in 2i condition (Guo et al. 2016). Indeed, ESCs 
cultured in 2i/LIF are considered morphologically uniform and express naïve 
pluripotency genes whereas ESCs cultured in Serum/LIF are heterogeneous for both (Guo 
et al. 2016; Kumar et al. 2014). Of note, as opposed to 2i/LIF, Serum/LIF condition is not 
associated with genomic instability like karyotype changes over extended culture periods 
(Hassani et al. 2014; Choi et al. 2017).  
Interestingly, epigenetic features like global DNA demethylation, missing X 
chromosome inactivation and low levels of bivalent (activator and repressor) histone 
marks on chromatin define naïve pluripotent ESCs. Even enhanced capacity for 
phosphorylation, or high mitochondria activity are considered hallmarks of naïve 
pluripotency (Hackett and Azim Surani 2014; Zimmerlin, Park, and Zambidis 2017; De 
Los Angeles et al. 2015). Therefore, switching of genetic and epigenetic features is used 
to convert naïve cells into primed pluripotent cells and vice versa (Bao et al. 2009; Silva 
et al. 2009; Tosolini and Jouneau 2015b). Intriguingly, cells cultured first in 2i/LIF and 
subsequently propagated in Serum/LIF adopt to the surrounding signaling cues which 
could be measured by gene expression changes. This shows that cell states exhibited in 
2i or serum conditions are highly plastic (Figure 3) (Weinberger et al. 2016).  
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Figure 3: Developmental plasticity of naive and primed pluripotent stem cells.  
ESC media is composed of signaling molecules in various combinations, all of which keep 
ESCs in a pluripotent state. The model depicts “relative naivity” within the spectrum of naïve 
and primed pluripotency. Naïve pluripotency cannot be described in absolute terms, as naïve 
cells can comprise features of primed pluripotent stem cells. Similarly, primed cells cultured 
in various conditions have different features and various degrees of naivety. As the naïve 
pluripotency feature decreases, the primed feature increases, which is reflected by the change 
in gene expression programs and epigenetic signatures as well as signaling circuitries. 
Adapted from Weinberger et al., (2016) with permission from Springer Nature under License 
Number 4653000646926. 
 
1.1.4  The primed state (EpiSCs) of pluripotency 
Mouse epiblast stem cells (EpiSCs) are established either by derivation from the post 
implantation epiblast (Brons et al. 2007; Tesar et al. 2007) or by ICM conversion in vitro 
using appropriate media conditions (Figure 3) (Guo et al. 2009; Tosolini and Jouneau 
2015; Brons et al. 2007). EpiSCs originate from a slightly more differentiated state 
compared to ESCs, thus, ESCs correspond to embryonic day 4.5 (E4.5) of development 
(Boroviak et al. 2014) whereas EpiSCs are the equivalent of E5.5 to E7.5 (Han et al. 
2010). This explains why pluripotent cells are categorized into “naïve” (ESCs) and 
“primed” (EpiSCs) pluripotency. Although both are considered pluripotent, their 
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epigenetic state, chromatin state, gene expression signature, transcriptional state, 
metabolism, and signaling mechanism differ vastly (Brons et al. 2007; Ying and Smith 
2017; Kalkan and Smith 2014). Besides differences, much overlap can be found, 
especially in gene expression. This suggests that pluripotency is a highly dynamic rather 
than fixed individual state which is confirmed by different degrees of naivety or priming 
among naïve and primed cells (Figure 3) (Weinberger et al. 2016). Primed cells, for 
instance, overlap with naïve cells in expression levels of core pluripotency factors such 
as Nanog, Oct4, Sox2, but not Klf2,4,5, Tbx3, Dax1 or Esrrb, which are dramatically 
downregulated in primed cells. Intriguingly, fate specific TFs such as Brachyury, FoxA2 
or Cer are only expressed in primed (Kalkan and Smith 2014) but not naïve cells. Taken 
together this suggests, that epiblast stem cells are a mixed population of lineage 
progenitors and pluripotent precursors. 
Similar to ESCs, EpiSCs can be kept in vitro for an extended period of time (Najm 
et al. 2011), which makes them a model system to study pluripotency exit and entry into 
lineage specification. EpiSCs can form chimeras when injected into post-implantation 
embryos. Moreover, EpiSCs differentiate to derivatives of all three major germ layers 
(Brons et al. 2007; Huang et al. 2012), but lack the ability of chimera formation upon 
blastocyst injection (Tesar et al. 2007; Han et al. 2010). Among many factors, the 
characteristic epigenetic profile of EpiSCs might contribute to its reduced plasticity (Han 
et al. 2010). Intriguingly, EpiSCs share distinctive properties with human ESCs 
(Chenoweth et al. 2010), thus EpiSCs are one among other model systems to study 
signaling cues and cell fate decisions in the context of human development.  
Since primed pluripotency is known to be dependent on Activin/Nodal signaling, 
EpiSCs are commonly cultured in Activin A and FGF2 containing media (Najm et al. 
2011). Although FGF is not strictly required, it improves the overall quality of the culture 
by reinforcing the efficiency of activin signaling (Brons et al. 2007) and inhibits 
spontaneous neuronal differentiation (Gritti et al. 1996). In addition, Activin A activates 
SMAD2/3 transcription factors (Figure 4) (Pauklin and Vallier 2015) which positively 
regulate Nanog (Brons et al. 2007) and therefore promote pluripotency. 
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1.2  Extrinsic and intrinsic signaling of pluripotency 
1.2.1  LIF dependent pluripotency 
Originally, mESCs were cultured on mitotically inactive feeder cells (embryonic 
fibroblasts). In 1988, leukemia inhibitory factor (LIF) was discovered as paracrine signal 
produced by these cells (Williams et al. 1988; Smith et al. 1988). Moreover, LIF mRNA 
was detected in both, the trophectoderm and blastocyst stage, which shows its pivotal role 
during early mouse embryogenesis (Nichols et al. 1996). Since then, LIF is the key media 
component for derivation and cultivation of mouse embryonic stem cells. As an 
interleukin 6 class cytokine, LIF sustains and facilitates the self-renewing and 
undifferentiated state of stem cells (Yoshida et al. 1994). In addition to paracrine 
signaling, LIF functions through an autocrine manner as it is produced by the LIF gene 
of mESCs (Yue et al. 2015).  
LIF affects three major signaling pathways in mESCs which were shown to 
maintain the pluripotent state of stem cells. The STAT3 signaling pathways, which 
facilitates self-renewal of pluripotent stem cells (Tai et al. 2014), the ERK signaling 
pathway, which promotes proliferation and differentiation (Cartwright 2005), and the 
AKT pathway, which was shown to foster cell survival through ß-catenin (Niwa et al. 
2009).  
On a molecular basis LIF binds to the low affinity LIF receptor (LIFR) which 
induces heterodimerization with the glycoprotein 130 (gp130) subunit. This 
heterodimerization results in the activation of the receptor associated Janus kinase 
(JAKs), phosphorylation of receptor docking sites and recruitment of STAT3 through 
Src-homolgy-2 (SH2) domains. In turn, signal transducer and activator of transcription 3 
(STAT3) is phosphorylated, translocates to the nucleus, and drives the expression of self-
renewal genes (Figure 4) (Yue et al. 2015). STAT3 also inhibits the differentiation of 
stem cells into mesoderm and endoderm progenitors by preventing the activation of 
lineage specific differentiation programs (Graf et al. 2011). At the same time the 
extracellular signal-regulated kinase pathway (ERK-pathway) is activated by LIF 
signaling where ERK phosphorylates itself in addition to cytoplasmic targets. Upon 
phosphorylation, ERK interacts with importin 7, which facilitates ERK translocation to 
the nucleus (Berti and Seger 2017). Nuclear ERK indirectly regulates gene expression 
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through TFs that in turn facilitate cellular proliferation (Figure 4) (Cartwright 2005). The 
third pathway activated by LIF signaling is the phosphatidylinositol-3 phosphate 
kinase/AKT pathway (PI3K/AKT pathway). Activated receptors proceed via stimulation 
of a lipid kinase PI3K which is bound by regulatory subunits or adapter molecules such 
as the insulin receptor substrate (IRS) (Hemmings and Restuccia 2012). PI3K 
phosphorylates phosphatidylinositol lipids in the plasma membrane, creating docking 
sites for PH-domain (pleckstrin-homology domains) containing kinases PDK1 and AKT 
(Burdon et al. 2002). As AKT becomes enriched, it is phosphorylated by PDK1 and gains 
full activity (Alessi et al. 1997). Activation of AKT results in substrate specific 
phosphorylation events in the cytoplasm and nucleus which mediates numerous cellular 
functions including growth, proliferation and survival (Hemmings and Restuccia 2012). 
In addition, the PI3K pathway has been shown to be involved in the maintenance of 
pluripotency (S. Watanabe et al. 2006; Paling et al. 2004). 
As media components were established empirically, LIF is used in various 
combinations with signaling cascade inhibitors such as GSK3, MEK or other inhibitors 
(Hassani et al. 2019). Therefore, it has to be kept in mind that depending on the media 
supplements used, cells respond differently to the signaling environment, which results 
in different wiring of pluripotency programs. These differences can be measured in 
transcriptional gene expression, epigenetic states or developmental potency. 
 
1.2.2  Chemically defined mESC culture conditions 
Pluripotency media supplemented with FBS is chemically undefined as it originates from 
animals and the exact content of signaling molecules cannot be determined, thus, FBS-
lots might vary (Zheng et al. 2006). In order to reduce the complexity of media 
formulations, chemically defined media were developed (Yasuda et al. 2018). 
Transcriptional profiling and RNA-Seq experiments on single cell level suggest that stem 
cells respond differently to the surrounding signaling cues depending on which media 
they are being cultured in (Hackett and Surani 2014). Examples for chemically defined 
media containing various combinations of signaling molecules are: 2i/LIF, BMP4/LIF or 
Wnt/LIF (Figure 4) (Ogawa et al. 2006; Tosolini and Jouneau 2015a; Qi et al. 2004).  
Interestingly, mESC pluripotency can be maintained under standard stem cell 
culture conditions, by dual inhibition (2i) of the GSK3 and MAP-kinase pathway (Sim et 
1 INTRODUCTION 
 10 
al. 2017). Although the combination of CHIR (GSK3 inhibitor) and PD (MEK inhibitor) 
is known to facilitate pluripotency without the addition of exogenously supplied 
cytokines, LIF is still present in pluripotent cells due to autocrine signaling (Graf et al. 
2011). Of note, although 2i/LIF media conditions recapitulate gene expression programs 
of the preimplantation embryo (Nichols and Smith 2012; Navarro 2018), one has to keep 
in mind that a hypomethylated DNA state exists only for few days in the developing 
embryo (Smith et al. 2014). Hence, increasing passage numbers of stem cell lines might 
increase the frequency of unwanted damaging events due to DNA hypomethylation 
(Oliveira et al. 2014; Gaztelumendi and Nogués 2014; Imreh et al. 2006). Indeed, ESCs 
cultured in 2i/LIF for extended periods of time were shown to have increased tendencies 
of acquiring genomic abnormalities (Choi et al. 2017; Hassani et al. 2014). It remains 
unclear whether these abnormalities are a by-product of nonspecific inhibitor activity or 
a result from intrinsically naïve pluripotency features like global DNA hypomethylation 
(Leitch et al. 2013). 
LIF supplemented serum free culture media is not sufficient to maintain mESC 
pluripotency (Ying et al. 2003). Interestingly, bone morphogenic protein 4 (BMP4) was 
characterized as the crucial component of serum which facilitates pluripotency in mESCs. 
Moreover, BMP4 was shown to be expressed from mouse embryonic fibroblasts (MEFs) 
which have been used as feeder layers to culture mESCs (Qi et al. 2004). As BMP4 
belongs to the transformation growth factor beta (TGFß) superfamily which also includes 
Activin, Nodal, Lefty, it is involved in the regulation of proliferation and differentiation 
(Ying et al. 2003). Therefore, BMP4 play essential roles during embryonic development 
(Massagué 1998) and is a crucial media component if Serum is absent. 
On a molecular level BMP4 binds to type I receptors which leads to a signaling 
cascade with phosphorylation of downstream proteins known as SMADs. Once activated, 
SMADs translocate to the nucleus where they function as transcription factors with 
coactivators to regulate ID (inhibitor of differentiation) gene expression (Ying et al. 
2003). Intriguingly, BMP4 supports mESC self-renewal by inhibition of ERK and p38 
MAP kinase pathways. Moreover, BMP4 and LIF were shown to have synergistic effects 
on the self- renewal of ES cells (Qi et al. 2004), preserve “multilineage differentiation, 
chimera colonization, and germ line transmission properties” (Wobus and Boheler 2005, 
p1). Thus, BMP4/LIF is an established pluripotency medium. 
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Figure 4: Extrinsic and intrinsic signaling of naive and primed pluripotency. 
Schematic representation of BMP4, LIF, WNT, FGF2 and Activin signaling in naïve and 
primed pluripotency. A) BMP signaling: BMP4 binds the type I BMP receptor which leads 
to a signaling cascade and phosphorylation of SMAD proteins. Activated SMADs translocate 
to the nucleus and drive the expression of ID genes. B) LIF signaling: LIF binds to the low 
affinity LIF receptor which induces dimerization with the gp130 subunit. In turn STAT3 is 
phosphorylated, translocates to the nucleus and promotes the expression of self-renewal 
genes. In addition, LIF induces the ERK and PI3K-pathway. C) Wnt signaling: During 
Wnt/ß-catenin signaling, Wnt interact with Frizzled through the cysteine-rich domain (CRD) 
which causes the inhibition of the ß-catenin destructive Axin complex (APC, CK1, GSK3) 
and accumulation of ß-catenin in the cytoplasm. ß-catenin then translocates to the nucleus 
and acts as transcriptional coactivator for transcription factors of the TCF family to activate 
Wnt responsive genes. D) FGF2 signaling: FGF2 binds the FGF receptor and results in 
autophosphorylation of the intracellular receptor region. The signal cascade is conveyed 
through JAK/STAT3, PI3K and ERK pathways which results in phosphorylation of c-MYC 
and activation of c-MYC responsive genes. E) Activin A signaling: Activin binds the Activin 
receptor and results in activation of the serine/threonine receptors which in turn trigger the 
phosphorylation of SMADs which act as transcriptional regulators by inducing or repressing 
transcription of their target loci. 
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The search of chemically defined pluripotency media led to the discovery of Wnt 
proteins (Nusse 2008). In the absence of MEFs, mESCs were able to self-renew due to 
high production of Wnt proteins. In combination with LIF, autocrine Wnt signaling was 
sufficient for ESC self-renewal in vitro (MacDonald et al. 2009). Wnt proteins bind to 
the Frizzled receptor which results in inhibition of glycogen-synthease kinase-3 (GSK3) 
and subsequent accumulation of ß-catenin in the nucleus which facilitates expression of 
target genes (Figure 4) (Sokol 2011). Intriguingly, Wnt signaling was documented to 
block neurogenesis and promote mesendodermal differentiation. It seems 
counterintuitive that Wnt signaling can promote both, self-renewal and differentiation 
(Berge et al. 2011). Yet, the interaction of Wnt signaling pathway with other spatially and 
temporally restricted pathways triggered by Nodal/Activin, FGF or BMP affects the 
outcome of signaling. This underlines the complexity of keeping the pluripotency 
network active and visualizes that independent signaling cues can be used to keep stem 
cells in pluripotent state.  
 
1.2.3  Core pluripotency factors  
Signaling pathways eventually result in the induction or repression of target gene 
expression in the nucleus (Figure 4). Pioneering work in delineating pluripotency 
networks identified three core pluripotency factors Oct4, Sox2 and Nanog (Loh et al. 
2006). This triad of TFs does not only form a pluripotency network of “autoregulatory 
and feedforward loops” (Boyer et al. 2005), they additionally downregulate their own 
genes to prevent overexpression. Indeed, overexpression of Oct4 and Sox2 is known to 
impair the homeostasis of mESCs by triggering differentiation (Niwa et al. 2000; Mitsui 
et al. 2003), whereas the inactivation of Sox2 or Oct4 resulted in embryonic lethality 
during pre-implantation stage in vivo (Chew et al. 2005). In vitro, reduced levels of Oct4 
resulted in trophectoderm differentiation (Nichols et al. 1998) whereas a 2-fold increase 
in Oct4 levels facilitated differentiation towards progenitor cells, positive for 
extraembryonic endoderm and mesoderm markers (Niwa et al. 2000). In addition, gain 
and loss-of-function experiments have shown, that Nanog-loss results in mESC 
differentiation whereas Nanog-gain facilitates pluripotency (Chambers et al. 2003; Mitsui 
et al. 2003). Therefore, TF levels of Nanog, Sox2 and Oct4 must be regulated precisely 
in order to maintain self-renewal of mESCs. 
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1.3  Transcriptional heterogeneity in mESCs 
1.3.1  Transcriptional heterogeneity in naïve mESCs 
Heterogenous gene expression is observed in vivo (Hupalowska et al. 2016) and in vitro 
(Torres-Padilla and Chambers 2014), albeit in lower levels in vivo. Transcriptional 
heterogeneity within pluripotent cells is indicative of dynamic changes that might occur 
when cells “drift between different states” (Singh et al. 2013, p1). The functional role of 
heterogeneity is heavily debated in the field with contrasting hypotheses. One hypothesis 
suggests that heterogeneity is transcriptional noise (Eldar and Elowitz 2010) with 
essentially no relevant function for cells (Allison et al. 2018), hence, random fluctuations 
of gene expression. The other hypothesis suggests that heterogeneity has a crucial role 
for a subset of cells within the pluripotent population (Torres-Padilla and Chambers 
2014). Those cells either self-renew or commit towards differentiation.  
It has been shown that ESCs respond differently to external cues, thus, their 
ultimate fate depends on a combination of intrinsic and extrinsic factors (Chambers et al. 
2007; Toyooka et al. 2008). Indeed, dynamic regulation of transcription factors and its 
co-expression with lineage specific genes has been suggested to create a “window of 
opportunity” for cells and their fate choice (Abranches et al. 2014). Depending on the 
sum of extracellular signaling and intracellular transcriptional heterogeneity, cells would 
either differentiate or continue to self-renew (Graf and Stadtfeld 2008). This plasticity in 
transient gene expression programs would allow the existence of timely restricted 
subpopulations within a culture (Abranches et al. 2013; Hackett and Azim Surani 2014). 
Therefore, “the pluripotent state is not well defined at the single-cell level but rather a 
statistical property of stem cell populations” (MacArthur and Lemischka 2013, p1). The 
origin of heterogeneity cannot be pinpointed to just one mechanism within cells. It is most 
probably a result of many cell features including transcriptional burst of genes (Suter et 
al. 2011; Raj and van Oudenaarden 2008), monoallelic or biallelic gene expression 
(Miyanari and Torres-Padilla 2012), multiple locations of TFs within the genome (Torres-
Padilla and Chambers 2014), post-transcriptional regulation via protein synthesis rather 
than mRNA production (Gambardella et al. 2017), or the modulation of signaling 
pathways (Hastreiter et al. 2018). 
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Transcriptional profiling of ESCs at bulk and single cell level revealed that stem 
cells routinely display heterogeneous gene expression (Messmer et al. 2019) especially 
with regard to transcription factors such as Rex1, Tbx3, Esrrb, Klf4, Stella (DPPA), 
Prdm14 or Nanog (Singer et al. 2014; Kumar et al. 2014). Absence of Nanog expression 
in Oct4 positive cells led to the discovery of TF heterogeneity using fluorescent Nanog 
reporter knock in cell lines (Chambers et al. 2007). Indeed, cells in Nanoghigh state 
comprised pluripotent gene expression and self-renewal whereas Nanoglow cells were 
prone to undergo spontaneous differentiation (Chambers et al. 2007; Singh et al. 2007). 
Single cell sorting and subsequent culture of Nanoglow cells revealed that cells can indeed 
revert back into a Nanoghigh state, although in lower rates than vice versa (Singh et al. 
2007; Abranches et al. 2013). Lower switching rates are explained by spontaneous 
differentiation of Nanoglow cells which in turn do not participate to the emerging 
undifferentiated population. Similar results were shown for Rex1high or Rex1low 
subpopulations. Cell sorting and re-plating of either Rex1high and Rex1low cells regained 
its counterpart (Toyooka et al. 2008). Similar to Nanog, conversion rates of Rex1low to 
Rex1high were lower than Rex1high to Rex1low. Which might be explained by epigenetic 
marks that may be partly reversible (Tompkins et al. 2012) and therefore regulate the 
transcriptional activity of Rex1 and Nanog genes. 
Compelling studies hint to functional relevance of heterogeneity in mESCs. Yet, 
heterogeneity continues to be controversially discussed in the field, especially since 
individual studies try to explain heterogeneity as an artifact of knock in reporters (Faddah 
et al. 2013), a result of monoallelic regulation (Miyanari and Torres-Padilla 2012) or as 
a result of poor cell culture conditions (Smith 2013). Indeed, TFs were shown to be more 
heterogeneously expressed in Serum/LIF as compared to 2i/LIF conditions. Bimodal 
genes expressed in Serum/LIF became unimodal expressed in 2i/LIF, suggesting that 2i 
might suppress one of the previously encountered cellular states (Zakary 2014). 
Moreover, recent findings from Hastreiter et al. show in a quantitative manner the 2i 
specific and selective effect against Nanoglow cells. Not only does 2i enrich for Nanoghigh 
populations, it also upregulates Nanog expression in Nanoglow cells and prevents its 
downregulation (Hastreiter et al. 2018). This selection of Nanoghigh cells would explain 
the homogeneous TF expression in 2i media as opposed to Serum/LIF conditions. 
1 INTRODUCTION 
 15 
Additional sources of heterogeneity are epigenetic regulations such as DNA 
methylation, histone tail modification or chromatin structure remodeling (Hayashi et al. 
2008; Toyooka et al. 2008; Yamaji et al. 2013). Interestingly, differentially methylated 
regions (DMRs) such as enhancers and promoters were shown to bear lineage specific 
methylation patterns (Nakanishi et al. 2010; Hattori et al. 2007). Indeed, locus specific 
bisulfate sequencing at known targets of methylation in Rex1low and Rex1high cells has 
shown that promoter methylation is elevated in Rex1low cells compared to its counterpart 
(Singer et al. 2014). Intriguingly, after state switching (Rex1low to Rex1high) cells 
recovered the methylation levels of Rex1high cells, demonstrating the reversibility in 
promoter methylation levels (Singer et al. 2014). Rex1low cells efficiently differentiate 
into somatic lineages in vitro but failed to contribute to chimeras upon blastocyst injection 
(Toyooka et al. 2008). Moreover, regulation of local chromatin structure by 
posttranslational modification of histone tails additionally affects gene expression which 
might explain in part heterogeneous gene expression. 
In addition to TFs, germ layer specific genes such as Gata6, Hex or Hes1 have 
been shown to be bimodally expressed (Graf and Stadtfeld 2008; Kobayashi et al. 2009). 
Indeed, Gata 6 and Nanog are known to be expressed at the 8-to-16-cell stage, with some 
cells expressing both markers (Bessonnard et al. 2014). Slightly later in development, 
Nanog and Gata6 are expressed in an random but mutually exclusive “salt and pepper” 
fashion which marks the initiation of lineage segregation (Chazaud et al. 2006; Singh et 
al. 2007). This suggests that heterogeneity has a functional role in embryonic stem cells.  
 
1.3.2  Nanog heterogeneity in mESCs – a case study 
Nanog was one of the first pluripotency associated TFs discovered to be heterogeneously 
expressed both in vivo and in vitro (Macarthur et al. 2012; Abranches et al. 2014). 
Whether Nanog heterogeneity is an intrinsic property of mESCs (Abranches et al. 2014), 
pivotal for their developmental potency, or merely a culture induced phenomenon (Smith 
2013) is controversially discussed in the field. Still, recent data on Nanog heterogeneity 
suggest a functional role in stem cells (Abranches et al. 2014). Indeed, cells in Nanoghigh 
state have been shown to self-renew whereas Nanoglow cells were prone to differentiate 
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(Singh et al. 2007). Where this Nanog heterogeneity originates from remains to be 
elucidated.  
Pioneering studies on Nanog heterogeneity suggest monoallelic expression in 
both, pre-implantation embryos and mESCs, cultured in Serum/LIF conditions (Miyanari 
and Torres-Padilla 2012). In addition, Nanog is believed to switch to biallelic expression 
in the naïve epiblast and mESCs, when cultured in 2i/LIF (Miyanari and Torres-Padilla 
2012). Thus, biallelic Nanog expression is proposed to result in homogeneous Nanog 
levels (Filipczyk et al. 2013), marking truly naïve stem cells. This notion was challenged 
by studies showing that biallelic Nanog expression varies as much in expression levels as 
other pluripotency factors (Faddah et al. 2013). Monoallelic Nanog expression seems to 
be functionally irrelevant as a central mechanism of regulating TF heterogeneity 
(Filipczyk et al. 2013). Instead it has been suggested, that regulatory mechanisms such as 
inherently noisy gene expression in stochastic bursts (Singer et al. 2014), Nanog 
autorepression (Fidalgo et al. 2012) or topology of pluripotency TFs and signaling 
networks (Macarthur et al. 2012) are the origin of Nanog heterogeneity. Indeed, studies 
on quantitative measurements of Nanog expression suggested that Nanog is biallelically 
expressed (Filipczyk et al. 2013) with stochastic promoter activation significantly 
contributing to the expression variability of Nanog (Ochiai et al. 2014). Therefore, bursty 
transcription (Suter et al. 2011) could explain dynamic fluctuations of TFs such as Nanog, 
Rex1 and Stella in mESCs. Interestingly, quantitative Nanog measurements showed that 
Nanog heterogeneity is observed in both, 2i/LIF and Serum/LIF conditions (Ochiai et al. 
2014; Abranches et al. 2014). These findings would be in line with in vivo data suggesting 
Nanog heterogeneity in the early and late stage blastocyst  as an intrinsic feature (Ohnishi 
et al. 2014). 
Although the majority of studies agrees on the necessity of Nanog downregulation 
for the differentiation of stem cells (Ohnishi et al. 2014; Torres-Padilla and Chambers 
2014; Trott and Martinez Arias 2013), the capacity of Nanoglow cells to interconvert 
remains to be elucidated. Studies on stochastic switching suggest that Nanoglow cells can 
indeed revert back to Nanoghigh state although in lower rates than vice versa (Singer et al. 
2014). Nair et al. questions the state switching potential of Nanog (Nair et al. 2015) and 
other pluripotency TFs. The authors suggest, that Nanoglow cells might be in fact low at 
the Nanog protein level but high at the Nanog mRNA level, which was neglected in 
1 INTRODUCTION 
 17 
previous quantifications. Single cell sorting of Nanoglow cells, would eventually result in 
Nanoghigh populations because of their high Nanog mRNA levels. Suggesting that those 
cells have never been Nanoglow to begin with (Nair et al. 2015).  
Intriguingly, results from transcription factor binding site analysis have shown 
that fate marker gene expression is not under direct control of the pluripotency associated 
network. This suggests the presence of spontaneously differentiating cells (Nair et al. 
2015). It has to be kept in mind that the pluripotent state is transient in the developing 
embryo and artificially stabilized in stem cell cultures (Weinberger et al. 2016). 
Therefore, stem cells could be in an unstable equilibrium allowing cells to exit 
pluripotency without any option to reverse lineage priming (Nair et al. 2015).  
 
1.3.3  Transcriptional heterogeneity in primed mESCs 
EpiSCs are believed to be less heterogeneous then ESCs. Yet, characterization of EpiSC 
cultures revealed heterogeneity for pluripotency (Han et al. 2010) and lineage specific 
factors (Kalkan and Smith 2014). The core pluripotency factor Oct4 has been shown to 
mark functionally different subpopulations in EpiSCs (Han et al. 2010). Intriguingly, 
Oct4low and Oct4high EpiSCs are functionally different in chimera contribution. Oct4low 
EpiSCs did not contribute to chimeras whereas Oct4high cells contributed normally to 
chimeras, albeit in lower rates then ESCs (Han et al. 2010). Therefore, EpiSCs comprise 
functionally distinct subpopulations in culture that resemble cells of early- and late stage 
post-implantation embryos. In addition to Oct4, lineage specific factors such as T, FoxA2 
and Cer were shown to be heterogeneously expressed in EpiSCs (Kojima et al. 2014; Han 
et al. 2010). This suggests that similar to ESC heterogeneity, EpiSC heterogeneity might 
have a functional role in development.  
  
1 INTRODUCTION 
 18 
1.4  Cell fate choice of naïve and primed mESCs 
1.4.1  Developmental potency of naïve mESCs 
ESC differentiation in vitro is believed to recapitulate in vivo developmental programs 
(Keller 1995). Yet, molecular mechanisms underlying cellular differentiation that yield 
both, mature and functional cell types, are still poorly understood. Current literature 
highlights TFs (Nanog, Oct4 and Rex1) as suitable markers for the differentiation state 
of stem cells as they are believed to act as molecular switches in activating or repressing 
differentiation gene expression programs (Niwa et al. 2000). Indeed, transcriptional 
profiling has shown that pluripotency associated TFs (Rex1, Oct4, Nanog, Klf5, Tbx3 or 
Sox2) comprise signatures of fate specific regulation (Weidgang et al. 2016). Thus, naïve 
pluripotency markers might be implicated in both, maintenance of self-renewal and 
lineage commitment.  
Oct4 and Sox2 targets, for example, were shown to create heterogeneities that bias 
cells to become either pluripotent or commit towards an differentiated fate (Hupalowska 
et al. 2016). In addition, Nanog levels affect self-renewal and differentiation propensities. 
Nanoghigh cells maintain self-renewal whereas Nanoglow cells facilitate differentiation 
(Abranches et al. 2014). Similar effects have been shown for Rex1high/Oct4high cells, 
which differentiated into primitive ectoderm and contributed to chimera formation as 
opposed to Rex1low /Oct4low cells, which differentiated towards fates of the somatic 
lineage with poor chimera contribution (Toyooka et al. 2008). Intriguingly, epigenetic 
and posttranscriptional regulations are also believed to be functionally relevant for stem 
cells differentiation and contribute to heterogeneity (Singer et al. 2014). Substantial 
differences in promoter methylation of Oct4 and Nanog have been shown to have major 
regulatory impact on stem cell self-renewal and differentiation (Hattori et al. 2007; 
Athanasiadou et al. 2010).  
In vitro differentiation of mESC (Figure 5) faces the major challenge to uncover 
the dynamics of gene expression programs implicated in cell fate choice. Current 
endoderm differentiation protocols use IDE1 (inducer of definitive endoderm) as 
pharmacological ingredient to activate the endoderm gene expression program (Borowiak 
et al. 2009). Successful endoderm derivation is quantified by FoxA2 or Sox17 expression 
levels (Sulzbacher et al. 2009). Mesoderm germ layer differentiation, on the other hand, 
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is mainly facilitated by LIF withdrawal in basal GMEM medium containing knock out 
serum replacement. Characteristic fate markers expressed upon mESC differentiation are 
Brachyury, EOMES, Vimentin or Mixl1 (Torres et al. 2012). Along the ectodermal 
lineage, retinoic acid and a signaling cocktail of N2B27 in neurobasal media pushes stem 
cells towards ectoderm progenitors. ES cells lose the pluripotent status and commit to 
neuronal fate over a 6-8-day period, which can be monitored by Tubb3 (ß-III-tubulin) 
expression (Ying and Smith 2003). 
 
Figure 5: In vitro differentiation of mESCs. 
Developmental potency of stem cells decreases upon differentiation from totipotentcy to 
unipotentcy. mESCs have the capacity to differentiate into the three major germ layers 
(endoderm, mesoderm, ectoderm), and beyond towards terminally differentiated cell types. 
Stem cell properties such as lineage potential and chromatin accessibility become more 
restricted, and expression of lineage specific genes in addition to DNA methylation increases 
throughout the differentiation process. Adapted from Berdasco and Esteller (2011). 
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1.4.2  Developmental potency of primed mESCs (EpiSCs) 
Hallmarks of pluripotency are the formation of teratomas and the contribution to chimeras 
in vivo (De Los Angeles et al. 2015). EpiSCs form teratomas and can be differentiated 
towards all three major germ layers in vitro (Figure 5) (Gardner 1968), but rarely 
contribute to chimera formation (Huang et al. 2012). Therefore, EpiSCs comprise limited 
developing potency (Brons et al. 2007). The functional difference of ESCs and EpiSCs is 
explained by global DNA methylation and differing signaling pathways. EpiSCs maintain 
their pluripotency through Activin/Nodal signaling (Brons et al. 2007) whereas mESCs 
are LIF dependent (Onishi and Zandstra 2015). 
Despite the notion that EpiSCs rarely contribute to chimera formation after 
blastocyst injection (Gardner 1968; Brons et al. 2007; Tesar et al. 2007), a growing body 
of literature suggests that EpiSCs can contribute to chimeras when injected into the post-
implantation epiblast (Huang et al. 2012). The inability of chimera contribution can be 
explained by their incompatibility with the environment of the pre-implantation epiblast 
(Huang et al. 2012). Blastocysts comprise embryonic day 3.5 (E3.5) whereas EpiSCs 
correspond to E5.5 ~ E7.5 of the developing embryo (Figure 2). Therefore, epiblast stem 
cells indeed form low-contribution chimeras when injected into the post-implantation 
epiblast (Huang et al. 2012). 
Since EpiSCs have the propensity to differentiate towards any cell type of the 
developing embryo (Brons et al. 2007), they should be unbiased in their fate choice. Yet, 
transcriptome profiling suggests a predisposition towards the endoderm lineage in 
differentiation assays (Figure 5), especially when Mixl1 was upregulated (Kojima et al. 
2014). Whether an endodermal fate bias is inherent to all EpiSCs or only present in a 
subpopulation of EpiSCs remains elusive. Current data suggest that Mixl1-early epiblast 
lines seem to be primed for endoderm differentiation due to a more efficient response to 
TGF-ß signaling (Kojima et al. 2014). Intriguingly, Liu et al. showed that Nodal inhibited 
EpiSCs differentiated preferentially towards the ectodermal fate (Liu et al. 2018). 
Inhibition of Wnt activity had no effect on fate choice whereas inhibition of Nodal activity 
enhanced ectoderm lineage propensity (Liu et al. 2018). This suggests that lineage 
specific stem cell lines could be generated by mimicking the signaling condition in the 
embryo for in vitro derivation and maintenance of EpiSCs. 
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Altered molecular characteristics and differences in signaling make EpiSCs a 
more advanced developmental stage in comparison to naïve ESCs (Nichols and Smith 
2009). The methylation status of pluripotency genes such as Stella and Rex1 is a perfect 
proxy to separate naïve (ESC) from primed (EpiSC) stem cells. These genes would be 
hypomethylated in ESCs but hypermethylated in EpiSCs (Bao et al. 2009; Hayashi et al. 
2008). Similar effects have been shown for germ cell specific gene promoters like Vasa 
or Fragilis (Iftm3) (Han et al. 2010). Therefore, the methylation status of genes is used as 
hallmark of ESC to EpiSC conversion. It is well accepted that ESCs can be directly 
converted to EpiSCs when FGF2 and Activin signaling is activated (Tosolini and Jouneau 
2015b), however, reverting EpiSCs back to ESCs is highly debated. Current literature 
suggests that switching the culture media of primed cells to 2i/LIF reverts EpiSCs back 
to a naïve pluripotency (Tosolini and Jouneau 2015a). Alternatively cells can be reverted 
by transgenic expression of key naive inducers such as E-Cadherin (Murayama et al. 
2015), Esrrb (Festuccia et al. 2012), the Krüppel-like factors Klf2/4/5 (Guo et al. 2009; 
Gillich et al. 2012; Jeon et al. 2016), cMyc (Hanna et al. 2009), or Nanog (Silva et al. 
2009). These findings suggest, that naïve and primed pluripotency is interconvertible but 
stabilized by their respective signaling environment.  
 
1.5  miRNAs in pluripotency and differentiation 
1.5.1  miRNA biogenesis  
microRNAs (miRNAs) are 21-25 nt long non-coding small regulatory RNAs implicated 
in stem cell self-renewal and differentiation by negatively regulating gene expression at 
the post-transcriptional level (Bartel et al. 2004; Lai 2003). miRNAs are either found as 
single gene insertions or miRNA clusters which contain two or more members originated 
from duplication events (Tanzer and Stadler 2004). Especially mammalian miRNA 
clusters contain miRNAs from different families which can be distinguished by their 
miRNA seed sequence (Kim and Nam 2006). 
Canonical miRNAs are located in introns of protein coding and non-coding genes, 
or at independent non-coding gene loci (Kim et al. 2009), either as individual genes or 
entire miRNA clusters. miRNAs can be transcriptionally regulated through their host 
gene promoters (Lagos-Quintana et al. 2003) or their own miRNA promoters. Expression 
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of the developmentally important miR-17/92 (Concepcion et al. 2012) and miR-379/miR-
410 (Labialle et al. 2014) clusters, for instance, is driven by their own miRNA promoter.  
 
 
Figure 6: Canonical miRNA biogenesis and post-transcriptional gene regulation. 
miRNAs are encoded as individual genes (monocistronic) or gene clusters (polycistronic) in 
introns and exons of protein coding and non-coding genes (intronic) or at independent non-
coding gene loci. Endonuclear Drosha and its cofactor Dgcr8 cleave the nascent pri-
microRNA (pri-miRNA) transcripts into ~ 70 nucleotide pre-miRNAs. Pre-miRNAs are 
shuttled from the nucleus to the cytoplasm by Exportin 5 and processed by Dicer into dsRNA 
duplexes, containing the mature miRNA (guide strand) and its complementary strand 
(passenger strand). Only one strand of the dsRNA is loaded onto Ago protein, forming the 
active RNA-induced silencing complex (RISC), while the passenger strand is degraded. 
Active RISC acts on its target by translational repression or mRNA cleavage depending on 
the level of complementarity between miRNA and its complementary sequence in the target 
3’UTR. The figure was reprinted from Treiber, Treiber, and Meister (2019) with permission 
from Springer Nature under License Number 4653001047582. 
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Clustered miRNAs are transcribed as polycistronic transcripts, which are 
processed to individual miRNAs. Mature miRNAs are derived by two subsequent 
cleavage stages catalyzed by RNase-II enzymes, Drosha and Dicer (Winter et al. 2009). 
After transcription of the nascent pri-miRNA transcript, endonuclear Drosha and its 
cofactor Dgcr8 cleave the RNA into a ~ 70 nt precursor (pre-miRNA) which is exported 
from the nucleus to the cytoplasm by Exportin 5, a Ran/GTP dependent 
nocleo/cytoplasmic cargo transporter (Lund et al. 2004). Cytoplasmic cleavage is 
performed by Dicer and its cofactor TRBP8, which yields the imperfect dsRNA duplex 
that contains the mature miRNA (guide strand) and its complementary strand (passenger 
strand) (Ketting et al. 2001). The mature miRNA is loaded onto the Argonaute (Ago) 
protein forming the active RNA induced silencing complex (RISC) (Hutvagner and 
Simard 2008) (Figure 6). 
 
1.5.2  miRNA activity is dependent on active RISC 
The RISC complex is composed of the Argonaute protein and short interfering RNAs 
(siRNAs) or micro RNAs (miRNAs) (Pratt and MacRae 2009). Active RISC is formed 
when the cleaved dsRNA duplex is handed to the Ago protein, which upon 
thermodynamic properties selects the mature miRNA, while the passenger strand is 
degraded (Hutvagner and Simard 2008). In order to study protein:RNA interaction in 
vitro, single-molecule fluorescence has been widely used (Yeom et al. 2011; Karunatilaka 
et al. 2010). This technique uses FRET (Förster resonance energy transfer) sensors and 
total internal reflection fluorescence microscopy to shed light into the dynamic search 
process of miRNA targeting (Salomon et al. 2016; Chandradoss et al. 2015). 
Recombinant human Ago2 was purified and loaded with fluorescently labeled miRNA 
let-7a, in order to study the miRNA to target search process in vitro (Salomon et al. 2016). 
Single-molecule fluorescence directly visualizes how active RISC searches for and 
identifies complementary miRNA target sites that were labeled with an acceptor 
fluorophore. The annealing rates were compared to naked let-7a RNA which revealed 
that RNA:RNA binding kinetics are not comparable to Ago2-miRNA:target binding 
kinetics (Chandradoss et al. 2015). Ago2 reshapes the binding properties of its loaded 
miRNA (Wee et al. 2012; Chandradoss et al. 2015; Salomon et al. 2016) in a way that 
miRNAs behave like an RNA binding protein rather than a free RNA (Salomon et al. 
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2016). Therefore, in-silico predictions of miRNA binding affinities give no valuable 
insights into target binding and miRNA affinities need to be experimentally determined. 
The Argonaute protein comprises three functional domains (Song et al. 2004): 
i) the mid domain, which binds the 5’anchor of the miRNA (Wang et al. 2008), ii) the 
PAZ domain, which binds the 3’end of the miRNA facilitating Ago loading (Song et al. 
2003) and iii) the PIWI domain, which catalyzes target cleavage (Liu et al. 2004). The 
Ago bound miRNA sequence on the other hand is separated into five functional domains 
that affect miRNA to target recognition. Namely, the 5’ anchor (nt 1), the seed sequence 
(nt 2-8), the mid or central region (nt 9-12), the 3’ supplementary region (nt 13-16), and 
the 3’ tail (nt 17-22) (Wee et al. 2012). The 5’ anchor is bound to the MID domain of 
Ago2 whereas the seed sequence is crucial for the initial targeting. The mid region, has 
the least functional role in target binding whereas the 3’ supplementary region has a role 
in miRNA to target stabilization. Nucleotides beyond 16th do not participate in target 
binding and are called the tail region (Klein et al. 2017). Intriguingly, the bottleneck of 
miRNA activity is RISC loading rather than miRNA expression itself (Hausser et al. 
2014). Therefore, miRNA activity cannot be inferred from miRNA expression levels. 
The seed sequence has been shown to determine the binding specificity of the 
active Ago complex (Lewis et al. 2005). Active RISC undergoes a conformational change 
that exposes the miRNA seed in a prehelical structure that lowers the entropic barrier to 
target binding (Schirle et al. 2014; Parker et al. 2009; Wang et al. 2008). Indeed, 
mismatches in the seed sequence (nt 2-8) but not central (nt 9-12) or 3’ supplementary 
region (nt 13-16), have been shown to negatively affect miRNA to target binding (Wee 
et al. 2012). Moreover, biochemical and structural studies (Chandradoss et al. 2015; 
Schirle et al. 2014; Salomon et al. 2016) suggest a step wise target recognition process, 
where the 5’ anchor (nt1) promotes the initial target recognition followed by sub-seed 
binding of the first three nucleotides (nt2-4), maintaining weak target interaction as an 
initial search process. Sub-seed binding is followed by full seed binding (nt 2-8) after 
Ago2 “undergoes a conformational change leading to the displacement of the helix-7 
loop” (Klein et al. 2017, p24), which promotes final seed binding of nt 6-8 (Figure 7) 
(Salomon et al. 2016; Schirle et al. 2014). Therefore, Ago2 changes from initial search 
mode (weak binding) into stable target recognition (strong binding) when the base pairing 
extends to the length of the entire seed (nt 2-8) (Chandradoss et al. 2015; Klein et al. 
2017). Interestingly, a six-meer seed match has been shown to be not sufficient for mRNA 
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target regulation in vivo (Brennecke et al. 2005). Therefore, the rule of seven applies 
(Cisse et al. 2012), where seven contiguous base pairs are needed for miRNA silencing. 
A larger seed sequence would impair with the function of the silencing complex, whereas 
a shorter seed sequence might result in a drop of the initial Watson-Crick base-pairing 
interaction (Cisse et al. 2012). 
Interestingly, siRNAs promote direct target cleavage; whereas miRNAs guide 
target binding, allowing Ago to recruit proteins that either trigger mRNA degradation or 
inhibit translational initiation or elongation (Huntzinger and Izaurralde 2011). RISC 
mediated target cleavage is frequent in plants, but infrequent in mammals. Therefore, the 
vast majority of miRNA targets in mammals are silenced through the recruitment of 
GW182 and co-factors, which result in translational repression or deadenylation and 
decay of target mRNAs (Guo et al. 2010; Meister 2013) 
 
 
Figure 7: Two-step target search process by Ago2. 
The 5’anchor of the mature miRNA binds the MID-domain of Ago and is stabilized in the 
functional RISC complex by the PAZ-domain. miRNA target search is a two-step process 
where the 5’anchor and sub-seed of nt 2-4 pair weakly complementary regions of potential 
targets for a quick search. Once bound, Ago2 undergoes a conformational change leading 
to a displacement of the helix-7 loop, allowing base pairing of nt 6-8. After full seed binding, 
more conformational changes take place before the bound Ago-miRNA complex becomes 
cleavage competent. This figure was reprinted from Klein et al. (2017) with permission from 
Elsevier under creative common license CC BY-NC-ND 4.0. 
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1.5.3  miRNAs in pluripotency 
miRNAs modulate pluripotency by directly regulating the 3’UTRs of TFs such as Oct4, 
Sox2, Nanog and Klf4 (Xu et al. 2009; Tay et al. 2008). Likewise, TFs directly regulate 
miRNA expression in ESCs, by either occupying miRNA gene promoter regions, to 
activate ESC specific miRNAs, or to silence a subset of miRNAs that are expressed in 
differentiated cell types (Tay et al. 2008). Chromatin immunoprecipitation (ChIP)-
sequencing assays confirmed that Nanog, Sox2 and Oct4 bind promoter regions of 
pluripotency associated miRNAs like the miR-106a/363 and miR-290/295 clusters in 
mESCs (Marson et al. 2008). 
The functional importance of miRNAs in the developing embryo and mESCs 
becomes apparent when the miRNA biogenesis machinery is impaired. Deletion of either 
Dgcr8, Dicer or Argonaute genes caused embryonic lethality before the post-implantation 
stage. Similarly, deletion of Dgcr8 in mESCs resulted in loss of self-renewal capacity 
(Kanellopoulou et al. 2005). Therefore, distinct miRNA signatures are indispensable for 
stem-cell self-renewal. Those signatures comprise miR-290, miR-106a, miR-200 and 
miR-142, which are upregulated in mESC pluripotency (Lichner et al. 2011; Sladitschek 
and Neveu 2015b; Balzano et al. 2018).  
One of the best characterized pluripotency associated miRNA cluster is the 
miR290/295 cluster, encoding miR-290, miR-291a, miR-291b, miR-292, miR-293, miR-
294 and miR-295 (Yuan et al. 2017). These miRNAs maintain self-renewal by targeting 
Dkk-1, a Wnt pathway inhibitor (Zovoilis et al. 2009) and regulate the shortened G1 phase 
in mESCs through the repression of key cell-cycle regulators, Rbl1 and Cdkn1a (Wang 
et al. 2008; Lichner et al. 2011). Furthermore, the transcriptional repressor 
retinoblastoma-like 2 (Rbl2) was identified as miR-290 target. Rbl2 recruits and targets 
histone methyltransferases, which leads to epigenetic transcriptional repression 
(Sinkkonen et al. 2008; Benetti et al. 2008). Thus, the miR-290 cluster indirectly controls 
the expression of methyltransferases which reduces heterochromatin formation, a 
hallmark of pluripotency.  
Another pluripotency associated microRNA is miR-142. The bimodal expression 
of miR-142 results in miR-142high cells with low ERK/Akt activity which keeps mESCs 
from differentiation, whereas mir-142low cells are able to exit the self-renewal circuitry 
(Sladitschek and Neveu 2015b). Taken together these findings suggest that mESC 
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specific miRNAs regulate target networks with critical role in the maintenance of ESC 
pluripotency. 
 
1.5.4  miRNAs in differentiation 
miRNAs fine tune gene expression (Baek et al. 2008) rather than act as binary On/Off 
switches (Sevignani et al. 2006). Subtle changes in gene expression seems to be sufficient 
to prime stem cells towards differentiation (Gu et al. 2016; Li et al. 2018), thus, miRNAs 
promote the transition from self-renewal to differentiation by either directly suppressing 
ESC self-renewal or stabilizing the differentiated state (Ando et al. 2017).  
Pluripotency associated transcription factors Nanog, Oct4 and Sox2 were shown 
to be negatively regulated by miR-134, miR-296 or miR-470 (Ong et al. 2015). Similarly, 
miR-200c, miR-203, and miR-183 cooperate to repress Sox2 and Klf4 (Wellner et al. 
2009), which facilitates the pluripotency exit and onset of differentiation. Interestingly, 
the miR-290/302 cluster is highly expressed at the late post-implantation epiblast stage, 
both in vivo and in vitro. Studies on pluripotency associated miRNAs suggest miR-290 
as key player in the transition from naïve to primed pluripotency, through downregulation 
of miR-290 (Marson et al. 2008), and upregulation of miR-302 (Gu et al. 2016) 
expression. On a molecular level, miR-290/302 represses AKT target genes and 
upregulates MEK, which promotes differentiation of stem cells. Therefore, miR-290/302 
expression levels are high during ESC to EpiSCs transition (Gu et al. 2016).  
As opposed to miR-290, let-7 miRNA family members are upregulated after 
pluripotency exit, and have been shown to be tightly regulated during ESC differentiation 
(Viswanathan et al. 2008). let-7 is proposed to acts as “anti-stemness” regulator with pro-
differentiation properties by directly targeting the expression of stemness factors c-Myc, 
Sall4 and Lin28 (Melton et al. 2010). In addition to functional roles in pluripotency exit, 
miRNAs are implicated in terminal differentiation of mESCs (Ivey et al. 2008). miR-1 
and miR-133 clusters, for instance, are highly expressed in mESCs and regulate the 
differentiation towards cardiac muscle cells (Ivey et al. 2008; Tao et al. 2015). 
Furthermore, miR-214 has been shown to target Ezh2, a polycomp group protein that 
occupies and represses promoters of mesoderm differentiation genes among others. 
Upregulation of miR-214 facilitates Ezh2 mRNA degradation which ensures the 
complete differentiation of skeletal muscle cells (Juan et al. 2009). Similar effects have 
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been reported for neuroectoderm differentiation, which is facilitated by miR-134 
upregulation. miR-134 is highly expressed in retinoic acid and N2B27 induced mESC 
(Tay et al. 2008), resulting in negative regulation of Nanog and LRH1 promoting 
neuroectoderm differentiation.  
 
 
Figure 8: miRNAs as regulators of differentiation and lineage commitment. 
Schematic representation of miRNAs promoting or inhibiting mESC differentiation. miRNAs 
regulate mESC differentiation at multiple levels: i) at the exit of pluripotency, ii) during 
transition of pluripotent states (ESC to EpiSCs) and iii) during terminal differentiation into 
functional cell types. Arrows indicate a promoting function whereas “dead ends” highlight 
inhibitory function of the respective miRNAs. Adapted from Ivey and Srivastava (2010) with 
permission from Elsevier under License Number 4653010446697. 
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Unlike mesoderm and ectoderm, definitive endoderm differentiation is facilitated 
by miR-338 and miR-340. CHIP-experiments revealed that promoter regions of 
endodermal fate marker Sox17 and FoxA2 are subject to histone acetylation (Fu et al. 
2011). miR-338 and miR-340 negatively regulate histone deacetylase (HDAC) activity 
which in turn promotes endoderm differentiation. Interestingly, the list of regulatory 
miRNAs with functional roles in lineage commitment and terminal differentiation is 
constantly expanding (Figure 8) (Cordes et al. 2009; Ivey and Srivastava 2010; 
Krichevsky et al. 2006). 
 
1.5.5  miRNA expression vs. miRNA activity 
The mammalian genome encodes thousands of miRNAs (Hammond 2015), yet, activity 
studies suggest that the minority is biologically active. Therefore, the functional 
‘miRNome’ of a cell is considerably smaller than currently presumed from miRNA 
expression analysis (Mullokandov et al. 2012). In order to identify miRNAs with 
biological impact in pluripotency and differentiation, miRNA activity rather than miRNA 
expression needs to be assessed. 
Pioneering miRNA studies measured miRNA expression by northern blot, qPCR 
(Fiedler et al. 2010), miRNA oligo microarray (Kong et al. 2009) or RNA-sequencing 
(Wang et al. 2009). These techniques are invasive, destroy the sample and provide only 
a snapshot rather than dynamic information of miRNA activity. Moreover, the acquired 
data yield a population average of millions of cells, which might not reflect true miRNA 
expression levels at single-cell resolution. Therefore, non-invasive techniques such as 
miRNA reporter constructs were developed.  
miRNA reporter constructs can be used at two stages of the miRNA biogenesis 
pathway: at the transcriptional level, using fluorescently labeled transcriptional reporter, 
or at the mature miRNA level (active RISC), using fluorescently labeled miRNAs target 
mimics. Traditional transcriptional reporter measure the expression rate of a given 
miRNA, but provide no information about its biological activity. Since the bottleneck of 
miRNA activity is RISC loading rather than miRNA expression (Hausser et al. 2014), 
transcriptional reporters yield no insights into the biological impact of miRNAs. 
Fluorescently labeled miRNA reporters that serve as miRNA target mimic, however, 
provide a direct readout for miRNA activity. One of the first miRNA activity reporters 
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was the luciferase assay, which assessed miRNA activity through complementary 
miRNA target sites placed downstream of the luciferase gene (Wang et al. 2011; Ji et al. 
2008). This technique, however, is again invasive and does not yield single cell resolution 
data. Therefore, I will use a single-cell fluorescent miRNA reporter that consists of a 
bidirectional promoter driving the expression of a normalizer (mCherry) and a miRNA 
sensor (Citrine). This approach is non-invasive and yields single cell resolution data of 
miRNA activity in live cells (Sladitschek and Neveu 2016). 
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2 AIM 
The mammalian genome encodes thousands of miRNAs, yet, only a minority is reported 
to have an impact on target gene expression. Therefore, the functional ‘miRNome’ of a 
cell is considerably smaller than currently presumed from miRNA expression analysis. 
miRNA expression data revealed that hundreds of miRNAs are differentially expressed 
during differentiation of embryonic stem cells (unpublished data). However, the 
biological activity of these miRNAs is poorly understood, as most studies cannot 
uncouple miRNA activity from miRNA expression levels. Therefore, my PhD project 
will focus on studying single cell miRNA dynamics during mouse embryonic stem cell 
differentiation towards the three major germ layers and measure miRNA affinities to a 
miRNA reporter in vivo. This will provide both, a comprehensive picture of the miRNA 
complement upon mESC differentiation and a determination of the affinity of individual 
miRNAs. In order to achieve these goals, I will subdivide my aim in the following steps: 
 
1. Develop fluorescent mESC reporter lines for all 162 miRNAs broadly conserved 
in vertebrates, to systematically assess the dynamics of miRNA activity upon 
mESC differentiation at single cell resolution. 
 
2. Experimentally determine miRNA affinities of conserved miRNAs in vertebrates 
using integrated measurements of miRNA activity and expression levels. 
 
3. Establish and validate a functionality test for gain- and loss-of-function 
experiments of miRNAs identified in this study.  
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3 RESULTS 
3.1  miRNA activity derived from miRNA reporter lines 
The mammalian genome encodes thousands of miRNAs (Hammond 2015), but only few 
have been shown to be biologically active. This implies that the functional ‘miRNome’ 
of a cell is considerably smaller than currently presumed from miRNA expression 
analysis (Mullokandov et al. 2012). In order to identify conserved miRNAs with 
biological role in both, pluripotency and differentiation, I used a ratiometric fluorescent 
miRNA reporter based on a bidirectional promoter that was previously developed in our 
lab (Sladitschek and Neveu 2016). 
The single-cell fluorescent miRNA reporter consists of a bidirectional promoter 
driving the expression of a normalizer (mCherry) and a miRNA sensor (Citrine) (Figure 
9). The miRNA reporter relies on a target site perfectly complementary to the miRNA in 
question. Since miRNA binding sites in the 3’UTR of target genes were shown to elicit 
more efficient repression than target sites in the 5’ or center regions of the respective 
target mRNA (Grimson et al. 2007), a fully complementary miRNA binding site was 
cloned into the multiple cloning site (MCS) which is located downstream of the sensor 
(Citrine) stop codon. The reporter was designed as such that the reporter ratio (R) is 
defined as the intensity of the Citrine signal (IDetector) over the intensity of the mCherry 
signal (INormalizer) and serves as a direct readout for the miRNA activity in single cells. 
 𝑅 = 	 𝐼&'(')(*+𝐼,*+-./01'+  
 
Since miRNA activities will be measured every 24 hours during a 6-day 
differentiation protocol, the reporter needed to be stably integrated into the cellular 
genome. The reporter plasmid possesses a cassette expressing a hygromycin resistance 
gene in order to streamline the generation of stable cell lines. I chose random transgene 
integration over homologous recombination as the latter suffers from inherently low 
efficiency. More importantly, random transgene integration is time-efficient and yields 
multiple clones with distinct integration sites and various reporter expression levels which 
rules out clonogenicity of biological replicates. Furthermore, the ratiometric approach 
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(Mukherji et al. 2011) corrects for locus specific transcriptional noise that might create 
measurement artifacts of the randomly integrated miRNA reporters (Figure 9).  
 
 
Figure 9: Ratiometric fluorescent miRNA reporter. 
The ratiometric miRNA reporter relies on the co-expression of the fluorescent detector gene, 
sensing the miRNA presence whereas the fluorescent normalizer gene serves as internal 
expression control. The bidirectional CAG promoter drives the expression of the back to back 
oriented normalizer (mCherry) and miRNA detector (Citrine). The complementary miRNA 
binding site is cloned into the multiple cloning site which is located downstream of the citrine 
stop codon. The ratio of the fluorescence intensity of detector levels over normalizer levels 
is a direct readout for miRNA activity in single cells. This miRNA reporter was developed by 
the previous PhD student in the lab. The figure was reprinted with permission from 
Sladitschek and Neveu (2015). 
 
The multiple cloning site downstream of the Citrine coding region enabled the 
time-efficient creation of miRNA reporter cell lines for all miRNAs conserved in 
vertebrates. Since this thesis project aimed to visualize the miRNA dynamics of all 
conserved miRNAs found in the mouse genome at single cell level, I successfully 
generated 162 stable transgenic reporter cell lines (Table 1).  
  
miRNA (  ) represses detector expression
Reporter ratio measures miRNA activity
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miRNA
binding site 
pA PromoterH2B mCherry pA 
Normalizer Detector
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Table 1: miRNAs conserved in vertebrates.  
let-7a-5p miR-96-5p miR-139-5p miR-190a-5p miR-219-5p miR-339-5p miR-411-5p miR-539-5p 
miR-1a-3p miR-99b-5p miR-140-3p miR-191-5p miR-221-3p miR-340-5p miR-421-3p miR-542-3p 
miR-7a-5p miR-101b-3p miR-141-3p miR-192-5p miR-223-3p miR-342-3p miR-425-5p miR-543-3p 
miR-9-5p miR-103-3p miR-142a-5p miR-193b-3p miR-224-5p miR-346-5p miR-431-5p miR-544-3p 
miR-10b-5p miR-122-5p miR-143-3p miR-194-5p miR-290-5p miR-34c-5p miR-433-3p miR-551b-3p 
miR-15a-5p miR-124-3p miR-144-3p miR-196a-5p miR-292-5p miR-361-5p miR-448-3p miR-590-3p 
miR-17-5p miR-124-5p miR-145a-5p miR-199a-5p miR-293-3p miR-365-3p miR-450a-5p miR-592-3p 
miR-18a-5p miR-125a-3p miR-146b-5p miR-200a-3p miR-294-3p miR-370-3p miR-451a miR-615-3p 
miR-19a-3p miR-125a-5p miR-147-3p miR-200b-3p miR-295-3p miR-374b-5p miR-455-5p miR-653-3p 
miR-21a-5p miR-126a-3p miR-148a-3p miR-202-3p miR-296-3p miR-375-3p miR-486-5p miR-708-5p 
miR-22-3p miR-127-3p miR-149-5p miR-203-3p miR-299a-3p miR-376b-3p miR-487b-3p miR-758-5p 
miR-23a-3p miR-128-3p miR-150-5p miR-205-5p miR-301a-3p miR-376c-3p miR-488-3p miR-873b 
miR-24-3p miR-129-5p miR-153-3p miR-208b-3p miR-302b-3p miR-377-3p miR-490-3p miR-874-3p 
miR-26a-5p miR-132-3p miR-154-3p miR-210-3p miR-302c-3p miR-378c miR-491-5p miR-875-5p 
miR-27b-3p miR-133b-3p miR-155-5p miR-211-5p miR-320-3p miR-379-5p miR-494-3p miR-876-5p 
miR-29b-3p miR-134-5p miR-181a-5p miR-212-5p miR-324-5p miR-381-3p miR-495-3p  
miR-30c-5p miR-135b-5p miR-182-5p miR-214-3p miR-328-3p miR-382-5p miR-496a-3p  
miR-31-5p miR-136-3p miR-183-5p miR-216a-5p miR-329-5p miR-383-5p miR-499-5p  
miR-33-5p miR-136-5p miR-184-3p miR-216b-3p miR-330-5p miR-384-3p miR-503-5p  
miR-92a-3p miR-137-3p miR-186-5p miR-217-3p miR-335-5p miR-410-3p miR-504-5p  
miR-93-5p miR-138-5p miR-187-3p miR-218-5p miR-338-3p miR-411-3p miR-505-3p  
 
The single sequence fully complementary to the respective miRNA in question, 
served as a target mimic for each miRNA. Full miRNA-to-target complementarity would 
result in degradation of the detector mRNA (Citrine) and allowed the quantification of 
the respective miRNA activity (Figure 9), at each day of a 6-day differentiation protocol 
towards the three major germ layers endoderm, mesoderm and neuroectoderm.  
miRNA reporter cell lines were established by transfection of Ab2.2 mESCs with 
the respective reporter plasmids. Hygromycin containing media was applied 24 hours 
after transfection in order to select for successfully transfected cells. After 7 days of 
antibiotic selection, clones positive for both, Citrine and mCherry expression were 
manually picked and propagated to constitute clonal cultures. 48 clones were picked for 
each reporter cell line and analyzed via flow cytometry analysis. Clones equally positive 
for Citrine and mCherry levels were propagated, frozen and subject to miRNA activity 
measurements in 6-day mESC differentiation protocols towards the three major germ 
layers (Figure 10). 
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Figure 10: Workflow of generating stable transgenic miRNA reporter cell lines. 
The scheme depicts the workflow for generating and screening clonal mESC lines stably 
expressing the respective miRNA reporter. Ab2.2 cells were transfected with the reporter 
plasmids. 7 days after Hygromycin selection, colonies positive for both, mCherry and Citrine 
were manually picked and propagated. Clones were assessed for equal expression of detector 
and normalizer using flow cytometry. Double positive clones were subject to activity 
measurements in a 6-day differentiation protocol, towards the three major germ layers. 
 
3.2  miRNA seed drives miRNA to target recognition 
The miRNA sequence can be separated into five functional domains: the 5’ anchor, the 
seed sequence, the mid or central region, the 3’ supplementary region, and the 3’ tail 
(Wee et al. 2012). Several lines of evidence suggest that the seed sequence is the main 
driving force of miRNA to target specificity (Brennecke et al. 2005; Bartel 2009). In order 
to determine whether a seed-only sequence would result in miRNA reporter repression 
comparable to its full-length complementary control, I generated two scrambled miRNA 
binding sites for endogenous miR-136-5p. The first construct was composed of a full-
length scrambled miRNA binding sequence (22 nt) which served as negative control. The 
second construct was composed of a functional seed binding region (nt 2-8) in an 
otherwise fully scrambled miRNA target sequence (scrambled 5’- and 3’region). miRNA 
activity of both reporter lines was compared to its full-length complementary control. 
miRNA to target specificity was measured by differentiation of stable transgenic miRNA 
and scrambled miRNA reporter cell lines, towards the endoderm lineage. Cells were 
differentiated in a 6-day differentiation protocol assessing the respective miRNA activity 
by flow cytometry analysis every 24 hours (Figure 11). 
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Figure 11: miRNA seed drives miRNA to target specificity. 
A) The miRNA sequence can be categorized into five functional domains: the 5’ anchor (nt1), 
the seed sequence (nt 2-8), and the 3’ region (nt 9-22) (which is further subdivided into 
central region (nt 9-12); supplementary region (nt 13-16) and 3’ tail (nt 17-22)). B) Stable 
transgenic cell lines expressing full-length miR-136-5p reporter or scrambled versions of the 
miR-136-5p binding sites. The fully scrambled miRNA binding site served as negative 
control. The full complementary miRNA binding site served as positive control. The “seed 
only” binding site was the sample in question. C) Distribution of miRNA reporter ratios for 
each day of a 6-day endoderm differentiation are plotted. Distributions are overlaid 
according to their respective reporter cell line: wild type (yellow), scrambled (red) and seed-
only (blue). 
 
miRNA activity was visualized by plotting the distribution of the reporter ratio 
for every day of differentiation. Since miR-136-3p expression levels are upregulated in 
RNA-Seq, I hypothesized that the miRNA reporter would be repressed upon mESC 
differentiation (Figure 11, C). Comparing the miRNA activity of the seed-only construct 
to its unedited control shows, that the seed sequence is indeed the main driver of target 
recognition. The seed-only reporter was downregulated in comparable range as the full 
complementary miRNA control. This confirms, that the miRNA seed sequence is 
sufficient to regulate its target mRNA. Next, I designed a prove-of-principle experiment 
to show that the miRNA reporter faithfully measures changes in miRNA expression 
levels. 
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3.3  Pluripotency associated miR-295 activity declines upon 
mESC differentiation 
The pluripotency associated miR-290 cluster has been shown to be downregulated upon 
mESC differentiation (Lichner et al. 2011; Yuan et al. 2017). Intriguingly, the miR-290 
cluster comprises seven miRNAs. As a representative of the cluster I chose miR-295-3p. 
Deep sequencing data of differentiated mESCs, suggested the downregulation of miR-
295-3p upon mESC differentiation in all germ layers (Figure 12, A). 
 
 
Figure 12: miR-295-3p activity decreases upon pluripotency exit. 
A) miRNA-295-3p expression levels were plotted for every day of a 6-day mESC 
differentiation towards the endoderm (yellow), mesoderm (red), and neuroectoderm (blue) 
lineage. B) miR-295-3p reporter cell line stably expressing normalizer (mCherry) and miR-
295-3p detector (Citrine). Every dot in the plot depicts a single cell. The color code depicts 
the cell density in the dot plot (blue (low) to red (high)). C) Distribution of reporter ratios 
were plotted for every day of differentiation and overlaid according to its respective germ 
layer. Movement of the distributions to the right indicate the downregulation of miR-295-3p 
activity upon mESC differentiation. 
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In order to demonstrate the general feasibility of miRNA activity measurements 
in mESC differentiation utilizing fluorescent miRNA sensors, I established the miR-295-
3p reporter cell line which should recapitulate miR-295 downregulation upon mESC 
differentiation. Since the miRNA reporter is a direct readout of miRNA activity, I 
expected an increase in miRNA detector fluorescence upon mESC differentiation as 
miRNA expression levels are downregulated (Figure 12, B). Indeed, miR-295-3p 
reporter ratios increased over a 6-day differentiation period, which confirmed the 
downregulation of miR-295-3p activity in all three germ layers (Figure 12, C). This result 
shows, that the miRNA sensor is regulated upon changing miRNA levels and can be used 
as direct readout of miRNA activity. 
 
3.4  miRNA crosstalk affects the miRNA-reporter 
In section 3.2, I found that the miRNA seed sequence is the main driver of miRNA to 
sensor specificity. As miRNAs are known to share identical seed sequences with 
redundant biological functions (Grimson et al. 2007), I was interested to determine the 
influence of overlapping miRNA sequences on miRNA reporter repression of 
functionally different miRNAs. miR-295 and miR-302b share the same seed sequence 
(Figure 13, A) but are largely unique for the remaining functional miRNA domains such 
as 5’ and 3’ region. I hypothesized that the miR-302b reporter would be influenced by 
the miR-295 seed sequence and vice versa. Therefore, I measured the effect of miRNA 
crosstalk in miRNA activity measurements.  
Deep sequencing data showed a downregulation of miR-295-3p and upregulation 
of miR-302b-3p expression levels upon mESC differentiation towards the endoderm 
lineage (Figure 13, B). Therefore, I expected a downregulation in miRNA reporter ratios 
for the miR-302b sensor. Surprisingly, miR-302b-3p reporter ratios, however, were 
upregulated (Figure 13, C). Moreover, miR-302b-3p activity profile recapitulated the 
miR-295-3p activity profile (Figure 12). This suggests, that miR-295-3p regulates the 
miR-302b reporter, probably due to miRNA crosstalk. The observed crosstalk might be 
explained by the high abundance of seven miR-290 cluster members as opposed to three 
members in the miR-302 cluster. A given miRNA reporter can therefore only faithfully 
measure the miRNA activity of unique and non-overlapping miRNA seed sequences. 
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Furthermore, this result visualizes how single miRNAs can regulate multiple mRNA 
targets (Bartel et al. 2004; Bartel 2009). 
 
 
Figure 13: The miRNA reporter can be affected by miRNA crosstalk. 
A) The miRNA seed sequence (nt 2-8) alignment is depicted for miR-295-3p : miR-302b-3p, 
and miR-295-3p : miR-302c-3p, respectively. miR-302c-3p represents the miR-302 cluster as 
non-overlapping seed candidate. B) miR-295-3p and miR-302b-3p expression levels are 
plotted over six days of mESC differentiation towards the endoderm germ layer. C) 
Distribution of miRNA reporter ratio is plotted for every day of a 6-day differentiation 
protocol towards the endoderm lineage. Movement of the distributions to the right or left 
indicate the down- or upregulation of miRNA activity, respectively. 
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The encountered miRNA crosstalk of the miR-302b reporter cell line with miR-
295, gave no valuable insight into miRNA activity of the miR-302 cluster. In order to still 
measure miRNA activity of the miR-302 cluster, I screened the five miRNA members for 
a unique and non-overlapping miRNA seed sequence. Seed sequence analysis revealed 
miR-302c-3p as candidate with non-overlapping and unique seed. Furthermore, sequence 
alignment revealed only a two nucleotide overlap of miR-302c-3p with miR-295-3p seed 
sequences (Figure 13, A). Since sub-seed pairing of nt 2-4 is postulated as initial seed to 
target binding but not target regulation (Schirle et al. 2014; Klein et al. 2017), I expected 
no crosstalk between miR-295-3p and the miR-302c-3p reporter. Indeed, miRNA activity 
data from mESC differentiation towards the endoderm lineage showed the expected 
upregulation of miR-302c-3p activity as suggested from the RNA-Seq dataset, with no 
measurable influence of the miR-295 seed (Figure 13, C). 
 
3.5  miR-21a-3p heterogeneity in pluripotent mESCs 
Heterogeneous expression of transcription factors (TFs) has been attributed a functional 
role in pluripotency and differentiation of mESCs (Tanaka 2009; Torres-Padilla and 
Chambers 2014; Martinez Arias and Brickman 2011). I postulate, that in addition to TFs, 
miRNAs might be heterogeneously expressed in stem cells. To address this question, I 
performed detailed mining of the RNA-Seq dataset acquired by the previous PhD student 
in the lab. Interestingly, miR-21a-3p was elevated in pluripotent state, which was 
surprising as miR-21a is known to have functional role in development, cancer 
(Kumarswamy et al. 2011) and mesenchymal stem cell differentiation (Sekar et al. 2015) 
but not pluripotency. 
Similar to TF heterogeneity, I hypothesized that mESCs might cycle through 
different miRNA levels while keeping the pluripotent state. Temporal regulation of 
miRNA levels might open a “window of opportunity” for external stimuli that trigger 
pluripotency exit. Indeed, confocal analysis of mESCs stably expressing the miR-21a-3p 
reporter revealed miR-21a heterogeneity in pluripotent state. Cells expressing low levels 
of miR-21a-3p appeared green whereas cells expressing high miRNA levels appeared 
orange to red (Figure 14, A).  
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Figure 14: miR-21a-3p heterogeneity in pluripotent state. 
A) Confocal analysis of pluripotent mESCs stably expressing the miR-21a-3p reporter 
construct. Cells in miR-21a-3p low state appear green whereas cells in miR-21a-3p high 
state appear orange to red. B) miR-21a-3p expression levels of pluripotent cells maintained 
in 2i/LIF or Serum/LIF media are plotted. Cells cultured in Serum/LIF were further sub-
divided into Nanoghigh and Nanoglow cells. C) miR-21a-3p expression levels are plotted over 
six days of mESC differentiation towards the endoderm, mesoderm and neuroectoderm 
lineage. 
 
Several lines of evidence suggest that stem cells cultured in Serum/LIF are more 
advanced in their differentiation potential compared to cells cultured in 2i/LIF 
(Weinberger et al. 2016). Therefore, I screened the RNA-Seq dataset of Nanoglow and 
Nanoghigh cells (unpublished data) for its respective miR-21a expression levels. 
Strikingly, Nanoglow cells showed high miR-21a expression levels whereas Nanoghigh 
cells expressed low levels of miR-21a (Figure 14, B). This result is reminiscent of studies 
showing that Nanog heterogeneity has a functional role in keeping pluripotency or 
facilitating the onset of differentiation (Abranches et al. 2014; Miyanari and Torres-
Padilla 2012). However, a comparable impact of miR-21a in mESC pluripotency would 
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need further investigation and was beyond the scope of this thesis project. Taken together 
these results suggest, that miR-21a-3p low cells maintain self-renewal while miR-21a-3p 
high cells are prone to exit pluripotency. Moreover, miR-21a-3p expression levels are 
strongly upregulated upon mESC differentiation towards endoderm, mesoderm and 
neuroectoderm lineage (Figure 14, C). Which suggests that miR-21a facilitates the 
differentiation process. 
 
3.6  Potentially germ layer specific miRNAs 
The previous chapter showed that miRNAs are implicated in pluripotency. Next, I was 
interested to determine miRNA dynamics upon stem cell differentiation. The pivotal role 
of miRNAs in terminal differentiated stem cells is well established in the field. miR-1 
and miR-133, for instance, have distinct roles in modulating the differentiation of 
skeletal- and cardiac muscle cells (Zhao et al. 2005; Chen et al. 2006). Whereas, miR-9 
and miR-142a were shown to be essential for the formation and proliferation of the 
neuronal lineage from ESCs (Krichevsky et al. 2006). Therefore, I hypothesized that in 
addition to terminal differentiation, miRNAs might be implicated in early cell fate 
decision making. To address this question, I screened the RNA-Seq data set (unpublished 
data) for outstanding and dynamically regulated miRNAs. I focused on conserved 
miRNAs with expression level changes of at least > 2 fold. In addition, I screened the 
dataset for potentially germ layer specific miRNAs.  
The > 2 fold expression level change cut off resulted in 98 miRNAs candidates 
for endoderm, 59 miRNAs for mesoderm and 69 miRNAs for the neuroectoderm lineage. 
A more stringent cut off of > 4 fold resulted in 33 miRNAs for endoderm, 37 miRNAs 
for mesoderm and 45 miRNAs for the ectoderm lineage (Figure 18). Interestingly, almost 
all miRNAs were found to be regulated in more than one germ layer. This suggests, that 
conserved miRNAs might primarily regulate their targets globally in a cooperative 
manner (Bartel 2009), which does not exclude single candidates from potentially being 
germ layer specific.  
miRNAs are considered germ layer specific if they are regulated in only one germ 
layer. Differentiation of mESCs towards the three major germ layers revealed that the 
miR-302 cluster is upregulated only in endoderm but not mesoderm nor neuroectoderm 
(Figure 15), which made this cluster an interesting candidate for further investigation. 
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The miR-302 cluster resides in an intron of the LARP7 gene and is encoded as single 
polycistronic transcriptional unit. The cluster is highly conserved among vertebrates and 
consist of five members: miR-302a, b, c, d and miR367. Interestingly, miR-302c and 
miR-367 do not share the miR-302 family seed sequence (Barroso et al. 2008; Chen et al. 
2015).  
Members of the miR-302 cluster seem to have a unique temporal expression 
profile throughout mESC differentiation as all miRNAs of the cluster peak in day 4 of 
differentiation whereas their magnitude of upregulation varied (Figure 15). Taken 
together the results suggest, that miR-302 is potentially germ layer specific, however, this 
finding needs further validation by gain- and loss-of-function experiments which were 
beyond the scope of this thesis project. 
 
 
Figure 15: Potentially endoderm germ layer specific miR-302 cluster. 
mESCs were differentiated towards the endoderm, mesoderm and neuroectoderm lineage, in 
a 6-day differentiation protocol. Samples were harvested every 24 hours and deep 
Sequencing was performed. miRNA expression levels of the miR-302 cluster were normalized 
to their levels in mESCs and visualized in a heat map for all major germ layers. 
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3.7  Dynamic regulation of developmentally important 
miR-17/92 and miR-379/410 cluster 
The previous chapter showed that entire clusters can be regulated upon mESC 
differentiation. Therefore, I was interested in the dynamic regulation of the 
developmentally important miR-17/92 and miR-379/410 clusters upon stem cell 
differentiation towards the three major germ layers. 
 
3.7.1 Upregulation of miR-17/92 cluster upon ESC differentiation  
Genomic manipulation of the miR-17/92 cluster revealed its pivotal role in fine-tuning 
signaling cascades and developmental pathways (Concepcion et al. 2012) throughout 
normal mouse development (Lu et al. 2007; Ventura et al. 2008). Multiple integration 
sites within the mammalian genome and its high conservation among vertebrates 
corroborates the importance of this cluster (Concepcion et al. 2012). The primary 
polycistronic transcript is processed into six mature miRNAs: miR-17, miR-18a, miR-
19a, miR-19b, miR-20a, and miR-92a (Figure 16, A). Intriguingly, miR-17 and miR-20a 
have been shown to directly target the TGF-ß receptor II, whereas miR-18a targets 
SMAD2 and SMAD4 (Mogilyansky and Rigoutsos 2013). SMAD proteins are known 
members of the TGF-ß/Nodal/Activin signaling pathway, which have a pivotal role in 
stem cell specification (Liu et al. 2018). Therefore, I was interested to determine 
previously unrepresented miRNA activity changes of the miR-17/92 cluster upon mESC 
differentiation (Figure 16). 
Deep sequencing data of differentiated mESCs revealed a highly dynamic 
regulation of the miRNA cluster in both, expression levels and temporal profile of 
miRNA expression (Figure 16, B). The majority of miRNAs showed subtle changes in 
expression levels, whereas single members like miR-19a, miR-20b or miR-92b, were 
highly upregulated. Especially miRNAs expressed form chromosome X seemed to be 
highly regulated compared to members of chromosome 5 and 14. This suggests that 
miR17/92 cluster fine tunes target gene expression through subtle changes in its 
expression levels. Of note, specific miRNA targets were not identified and beyond the 
scope of this thesis project.  
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Figure 16: Dynamic regulation of the miR-17/92 cluster upon mESC differentiation. 
A) Schematic representation of the miR-17/92 polycistron. The miR-17/92 cluster encodes a 
pri-miR that yields 6 mature miRNAs. Based on seed sequence homology, these six miRNAs 
belong to four miRNA families (each color represents one family). miR-17/92 has two closely 
related homologues in mammals, the miR-106a/363 and miR-106b/25 clusters. These 
homologous clusters contain subsets of the miR-17/92 cluster with conserved genome 
arrangement on chromosome 5 and X. miRNAs highlighted in black represent each miRNA 
family in the screen (see C). B) mESCs were differentiated towards endoderm, mesoderm 
and neuroectoderm lineage in a 6-day differentiation protocol, where miRNA expression 
levels were assessed every 24 hours and depicted as heat map. C) mESCs were differentiated 
towards all major germ layers. miRNA activity was assessed using corresponding miRNA 
reporter cell lines which were analyzed via flow cytometry every 24 hours throughout a 6-
day differentiation protocol. Resulting miRNA activity data were visualized as heat map. 
Each miRNA corresponds to a miRNA family (see A).  
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The miRNA activity data recapitulate trends observed in deep sequencing data. 
Due to single cell resolution of the activity dataset, subtle changes in miRNA activity 
could be resolved which were previously unrepresented due to population average of deep 
sequencing data. The activity data show that miR-17/92 cluster was upregulated 
throughout mESC differentiation. Interestingly, miR-19 and miR-92a were upregulated 
right after onset of mesoderm differentiation as opposed to late regulation (d4-d5) in the 
endoderm lineage (Figure 16, C). Interestingly, miRNA activity peaked at different days 
of differentiation, which suggests that their temporal profile might play a role in 
development. Taken together, these data suggest a cooperative effect of the miR-17/92 
cluster rather than germ layer specificity.  
 
3.7.2 miR-379/410 activity dynamics upon mESC differentiation 
Another developmentally important miR-379/410 cluster is located at the imprinted 
DLK1-Dio3 region. Correct dosage of imprinted genes encoded by this locus have been 
shown to be crucial for embryonic growth and neuronal development (Rocha et al. 2008). 
Since the miR-379/410 locus is the largest known miRNA cluster in placental mammals 
and conserved among vertebrates, it was subject to further investigation.  
The cluster comprises 40 miRNAs out of which 27 are represented in my miRNA 
activity dataset (Figure 17, A). Before assessing miRNA activities at single cell 
resolution, I was interested in miRNA expression dynamics of this cluster (Figure 17, 
B).  
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Figure 17: miRNA dynamics of the imprinted DLK1-Dio3 locus. 
A) Schematic representation of the imprinted Dlk1-Dio3 domain located on chromosome 12, 
harboring the miR-379/410 cluster. The cluster is conserved among vertebrates and 
comprises 40 miRNAs out of which 27 (bold) are represented in the miRNA activity dataset. 
Only miRNAs of the maternal strand are actively transcribed. Gtl2 (lncRNA), anti RTL1, 
Rian and Mirg are poorly characterized ncRNAs. Paternally expressed protein coding genes 
(Dlk1, RTL1, Dio3) are symbolized in blue rectangles, whereas maternally transcribed 
miRNAs are depicted in pink stem loops. B) miRNA activity data derived from corresponding 
reporter cell lines and miRNA expression levels derived from deep-sequencing are visualized 
in heat maps. C) The cumulative fraction was plotted over the corresponding correlation 
coefficient for 27 randomly chosen conserved miRNAs (grey) and 27 miRNAs of the miR-
379/410 cluster (black), for both miRNA activity and RNA-Seq data. 
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Similar to miR-17/92, also miR-379/410 cluster expression levels were overall 
upregulated in mESC differentiation. Surprisingly, almost all miRNAs were elevated 
throughout neuroectoderm differentiation, whereas miRNAs were tightly regulated in 
their temporal profile for mesoderm and endoderm differentiation. Furthermore, miRNA 
expression levels were on average earlier upregulated (from day 2) in endoderm as 
compared to mesoderm germ layer (from day 3). This suggests that the temporal profile 
of miRNA expression might impact mESC differentiation.  
The miRNA activity dataset recapitulated RNA-Seq results, with overall 
upregulation of miRNA activity for the entire cluster. However, the temporal profile 
differed dramatically comparing miRNA activity and expression levels (Figure 17, B). 
miRNA expression levels were elevated right after onset of differentiation in the 
neuroectoderm lineage, whereas miRNA activity was ramped up from day 3 of 
differentiation. Interestingly, miRNA activity in endoderm germ layer was upregulated 
even later, it increased significantly from day 5 onwards. Less stringent was the 
upregulation of miRNA activity in mesoderm germ layer. Here miRNAs could be 
categorized into early, mid and late regulated miRNAs. Taken together, these results 
show that miRNA activity cannot be inferred from miRNA expression analysis alone. 
Moreover, the comparison of miRNA activity and corresponding miRNA expression 
levels indicates that the temporal regulation of miRNA activity might have a crucial role 
in stem cell differentiation. 
The co-expression of a large number of miRNAs from the same cluster offers the 
opportunity to test the reproducibility of my miRNA activity dataset. Indeed, it relies on 
independent measurements of individual stable reporter mESC lines, as opposed to 
miRNA-Seq, which measures the expression levels of all miRNAs in one sample. 
Changes in activity levels of miRNAs from the miR-379/410 cluster were highly 
correlated, whereas activity levels of 27 miRNAs taken at random from the list of 162 
conserved miRNAs, did not show any correlation in their activity changes during 
differentiation. A similar result was obtained when analyzing miRNA-Seq data (Figure 
17, C). This result shows, that miRNA expression from the same cluster is highly 
correlated and not random. In addition, my miRNA activity measurements could be 
reliably compared across miRNAs. 
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3.8  Dynamic regulation of conserved miRNAs upon mESC 
differentiation 
Having shown that developmentally important miRNA clusters are upregulated upon 
mESC differentiation, I was interested in the global miRNA activity dynamics of 162 
conserved miRNAs and their temporal regulation throughout a 6-day differentiation 
process. Therefore, I established 162 stable transgenic miRNA reporter cell lines and 
differentiated each line towards mesoderm, endoderm and neuroectoderm fate. miRNA 
activity was assessed every 24 hours throughout a 6-day differentiation protocol using 
flow cytometry analysis. The resulting miRNA activity was depicted in a heat map, where 
every column represents a condition and every line the respective miRNA.  
The results indicate that the majority of conserved miRNAs are upregulated upon 
mESC differentiation. Surprisingly, the number of upregulated miRNAs in the activity 
dataset almost matched the number of > 2-fold upregulated miRNAs in the expression 
level dataset (Figure 18, A). This shows, that even weakly expressed miRNAs have 
detectable changes in activity during stem cell differentiation. miRNA expression levels 
derived from RNA-Seq might mask interesting miRNA candidates due to population 
average data. To overcome this obstacle, I used miRNA reporter cell lines analyzed via 
flow cytometry which give access to germ layer specific single cell resolution data. The 
reporter cell lines revealed that miRNA activity is gradually upregulated upon 
differentiation for the majority of conserved miRNAs. Few miRNA candidates also 
peaked in intermediate days of differentiation. Based on temporal resolution of miRNA 
activity, miRNAs can therefore be grouped into early, mid and late regulated candidates. 
Furthermore, specific groups of miRNAs seem to be either upregulated in all three or in 
a combination of at two germ layers (Figure 18, B). Taken together, these data suggest a 
cooperative miRNA effect with specific temporal activity profile which might be pivotal 
to drive cell fate choice and stem cell differentiation. Yet, the impact on fate choice would 
need further validation. 
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Figure 18: Dynamic miRNA activity regulation upon mESC differentiation. 
A) Schematic representation of generating both, the miRNA activity dataset and the miRNA 
expression level dataset. mESCs were differentiated towards the mesoderm, endoderm and 
neuroectoderm lineage in a 6-day differentiation protocol. miRNA expression levels and 
miRNA activity were assessed every 24 hours. The table summarizes the number of miRNAs 
with changing miRNA activity, in addition to the number of miRNAs upregulated in 
expression levels (2-fold and 4-fold). B) 162 miRNA reporter cell lines were differentiated 
towards the major germ layers. miRNA activity data were depicted in a heat map where every 
column represents an experimental condition and every line represents a given miRNA.  
 
To further investigate whether changes in miRNA activity could distinguish fate 
choices, principle component analysis (PCA) was performed on the miRNA activity 
dataset. Divergence in miRNA profiles occurred 48 hours after onset of differentiation, 
where each germ layer followed a specific trajectory (Figure 19). This result is in line 
with Waddington’s concept of “progressive restriction of cell differentiation potential 
during normal development” (Ladewig et al. 2013, p1). 
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Figure 19: miRNA activity data distinguish cell fate choice. 
PCA analysis was performed on miRNA activity data (Figure 17) of conserved miRNAs in 
vertebrates. miRNA activity was derived from reporter cell lines differentiated towards 
mesoderm, endoderm and neuroectoderm germ layer. 
 
3.9  miRNA activity vs. miRNA expression levels  
miRNA dynamics in stem cell differentiation is currently studied on the basis of miRNA 
expression levels using large RNA-Seq datasets (Li et al. 2018; Castel et al. 2018). 
However, miRNA activity cannot be inferred from expression analysis alone since the 
bottleneck of miRNA activity is Ago loading rather than miRNA expression (Hausser et 
al. 2014). Moreover, miRNA expression does not prove discernable activity as the 3’UTR 
of a potential target mRNA might not be accessible (Szostak and Gebauer 2013). These 
and other factors suggest that the functional ‘miRNome’ of a cell is considerably smaller 
than currently proposed from miRNA expression studies. Therefore, I was interested in 
similarities and differences of two miRNA candidates residing in the same transcriptional 
unit comparing miRNA expression levels versus miRNA activity. 
miR-495-3p and miR-136-5p are members of the previously introduced miR-
379/410 cluster. Both miRNAs yield mature miRNAs and are processed from the same 
transcript (Figure 17). Intriguingly, their miRNA expression levels differ 7-fold (Figure 
20). One could assume that miR-495 activity does therefore exceed miR-136 activity due 
to its higher expression levels. Strikingly, this 7-fold difference in expression was not 
reflected in the miRNA activity levels. Both miRNAs displayed comparable activity 
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changes upon differentiation. These data suggest that miR-136-5p is more potent 
compared to miR-495-3p, as lower miRNA expression levels result in the same miRNA 
activity. This finding can probably be explained by differences in miRNA sequence 
composition of miR-136 and miR-495, which likely results in miRNA affinity 
differences.  
 
Figure 20: miRNA activity cannot be inferred from miRNA expression levels. 
A) miRNA expression levels of miR-495-3p and miR-136-5p were plotted for each day of a 
6-day differentiation period towards the neuroectoderm lineage. Both miRNAs belong to the 
miR-379/410 cluster and are expressed from the same transcriptional unit. B) miRNA activity 
was assessed by differentiation of corresponding miRNA reporter cell lines towards the 
neuroectoderm lineage. 
 
3.10  miRNA activity and miRNA expression levels give access 
to miRNA affinity 
In order to confirm that the miRNA reporter ratio is a direct proxy for miRNA activity, 
miR-142-3p reporter was calibrated by the previous PhD student. The calibration was set 
up as follows: the miR-142-3p reporter ratio of mESC subpopulations expressing various 
levels of miR-142-3p was measured by flow cytometry and subsequently FACS purified 
to extract total RNA. Deep sequencing was performed on FACS purified cells, and 
normalized miRNA detector levels were plotted over corresponding miR-142 expression 
levels, which resulted in a calibration curve (Figure 21). The dependence of the detector 
levels D on the miR-142-3p concentration M (miRNA levels) followed a Hill’s equation 
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with non-cooperative binding, where K (miRNA affinity) is the binding constant and n is 
the Hill coefficient of the interaction.  
 𝐷 = 11 + 𝑀6/𝐾6 
 
Adjustment of the detector mRNA expression levels as a function of miR-142-3p 
levels with Hill’s equation resulted in n = 1,07 ±	0,04. Since miRNA activity depends on 
both, miRNA expression and miRNA affinity, miRNA activity gave direct access to in 
vivo miRNA affinity. 
 
 
Figure 21: Calibration of the miRNA reporter. 
Adjustment of the detector mRNA expression levels as a function of miR-142-3p expression 
levels for 12 independent biological samples (blue dots: experimental data measured by deep 
sequencing in FACS purified populations). Detector and miR-142-3p expression levels were 
quantified by RNA-Seq on matched mRNA and miRNA libraries prepared from the same total 
RNA sample. Data were fitted using the Hill’s equation with non-cooperative binding (red 
line; shaded area: fit confidence interval). The calibration experiment was conducted by the 
previous PhD student in the lab. The figure was reprinted with permission from Sladitschek 
and Neveu (2015). 
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3.11  Expression based miRNA affinity 
Having shown that miRNA reporter cell lines faithfully measure miRNA activity and the 
Hill function gives access to previously unrepresented miRNA affinity, I aimed to 
determine miRNA affinities of all conserved miRNAs in vertebrates. miRNA affinity is 
currently predicted from the miRNA sequence using various bioinformatic tools. Those 
programs apply free-energy prediction (∆G) thermodynamic calculations in order to 
derive miRNA binding affinities for different targets (Sethupathy et al. 2006). This 
approach disregards the fact that the minority of expressed miRNAs are biologically 
active (Mullokandov et al. 2012). Moreover, these tools predict miRNA to target 
interaction based on full length miRNA complementarity. However, miRNA binding 
studies show that miRNAs bind through partial sequence complementarity (Grimson et 
al. 2007). Therefore, my aim was to experimentally determine miRNA affinities for 162 
conserved and biologically active miRNAs.  
 
 
Figure 22: Expression-based miRNA affinity. 
A) Schematic representation of generating the miRNA activity dataset. 162 miRNA reporter 
cell lines were differentiated towards the mesoderm, endoderm and neuroectoderm lineage. 
The miRNA reporter ratio was measured every 24 hours, over a 6-day differentiation period 
using flow cytometry analysis. B) miR-7a-5p reporter ratios were plotted over the 
corresponding miR-7a-5p expression levels, for all major germ layers (6 days x 3 germ layers 
= 18 data points). Fitting a Hill function with non-cooperative binding gave access to the 
miRNA affinity for this specific miRNA. 
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Since the Hill equation gives access to miRNA affinity through its binding 
constant (k), I postulate, that an integrative approach of miRNA expression levels and 
miRNA activity changes in mESC differentiation yields experimentally determined 
miRNA affinities for the first time. To visualize the expression-based miRNA affinity 
concept, I plotted the miR-7a-5p reporter ratios, as an example, over the corresponding 
miRNA expression levels for every day of a 6-day differentiation towards the major germ 
layers which resulted in 18 data points (6 days x 3 germ layers = 18 data points). These 
data points were fitted using the Hill function with non-cooperative binding and enabled 
the derivation of the miR-7a-5p affinity (Figure 22). 
The expression-based affinity approach can derive the affinity for any miRNA 
with measurable changes in expression during mESC differentiation. Therefore, I 
generated stable transgenic reporter cell lines for 162 conserved miRNAs and 
differentiated those towards the mesoderm, endoderm and neuroectoderm lineage. In 
order to determine whether miRNAs have comparable affinities, I plotted miRNA 
affinities of all measurable conserved miRNAs over their respective expression levels 
(Figure 23).  
 
 
Figure 23: Expression based miRNA affinities for 96 conserved miRNAs. 
Expression based miRNA affinities were plotted over their corresponding miRNA expression 
levels for 96 conserved miRNAs (RPM: reads per million mapped reads). 
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Strikingly, miRNA affinities can span several orders of magnitude, which shows 
that miRNAs differ vastly in their respective potency. In addition, miRNA affinity was 
negatively correlated with miRNA expression levels. This suggests that weakly expressed 
miRNAs can be as potent, or even more potent as highly expressed miRNAs. 
Furthermore, these data confirm that miRNA expression levels do not necessarily 
correlate with miRNA activity. Of note, this approach only yields the miRNA affinity for 
candidates with expression level changes upon differentiation. This was true for 96 
miRNAs from a total of 162 candidates. The remaining miRNA affinities could not be 
determined as these miRNAs were either not expressed under these conditions or did not 
change in miRNA expression. In both cases, the expression-based method would not be 
applicable to derive miRNA affinities. Thus, I developed an alternative approach using 
miRNA KO reporter cell lines. 
 
3.12  Knock out based miRNA affinity 
In order to determine miRNA affinity for miRNAs with constitutive expression during 
differentiation, the miRNA expression levels have to be artificially manipulated in a 
controlled manner. CRISPR/Cas9 mediated deletion of miRNA alleles allows such a 
precise perturbation. Therefore, I established miRNA CRISPR/Cas9 knock out (KO) cell 
lines for a subset of miRNAs. Since the dependence of the reporter ratio on miRNA levels 
follow a Hill’s equation (Figure 22, B), I postulate that miRNA affinity can be calculated 
from a non-linear equation consisting of two main variables: miRNA expression levels 
and miRNA activity in pluripotent state. Thus, the homozygous KO of a given miRNA 
candidate within its respective miRNA reporter cell line, would yield the miRNA affinity 
(Figure 24, B).  
miRNAs entail more constraints compared to knocking out protein coding genes. 
Indeed, an insertion or deletion (indel) in the nucleotide sequence of a protein coding 
gene can result in a frame shift of the amino acid sequence, and usually introduces 
premature stop codons. For miRNAs, however, the entire 22 nt sequence has to be deleted 
as miRNAs comprise independent functional domains which can bind their respective 
target sequence (Broughton et al. 2016; Grimson et al. 2007). Therefore, the single strand 
guide RNA for CRISPR/Cas9 was designed as such that it would bind in close proximity 
or even within the miRNA sequence to be knocked out (Figure 24, A). The resulting 
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homozygous miRNA KO cell line was used to assess the reporter ratio of the true null of 
miRNA expression in pluripotent state. In addition, the unedited (wt) cell line was used 
to assess miRNA expression levels by deep sequencing. Having measured both, miRNA 
activity and miRNA expression levels, enabled me to calculate the miRNA affinity 
(Figure 24, B). 
 
 
Figure 24: Direct miRNA affinity measurement. 
A) miRNA CRISPR/Cas9 KO cell lines were generated using the respective miRNA reporter 
cell lines. KO of the entire miRNA sequence was validated by PCR and sanger sequencing. 
Flow cytometry analysis was performed on reporter cell lines of both, unedited miRNA 
reporter cell line and miRNA KO reporter cell line. B) Hills equation with non-cooperative 
binding gave access to miRNA affinity. miRNA expression levels in pluripotent mESCs were 
determined by deep sequencing. miRNA activity was assessed by flow cytometry for both, 
unedited miRNA reporter cell line and miRNA KO reporter cell line (see C).  
C) Flow cytometry analysis was performed for unedited and KO cell lines of each miRNA in 
question. miRNA reporter ratio of KO cell lin was used as true null of miRNA expression. 
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I chose two miRNAs with significant difference in their respective expression 
levels in the pluripotent state, namely miR-21 and miR-141. Interestingly, both miRNAs 
differ 360-fold in expression levels. Therefore, I hypothesized that the miRNA reporter 
repression in miR-21 KO cell lines might be more dramatic than the reporter repression 
in miR-141 KO cell lines. Strikingly, miR-141 KO lines showed a 19-fold miRNA 
reporter repression whereas miR-21 KO lines resulted in a 2-fold repression (Figure 24, 
C). This suggests, that miR-141 is more potent compared to miR-21a, despite its higher 
expression levels. Taken together, these data validate my previous observation that 
weakly expressed miRNAs can be as potent as/or even more potent then highly expressed 
ones. Moreover, I could show that miRNA affinity cannot be inferred from miRNA 
expression levels alone. 
Among the 41 miRNA candidates without expression changes during 
differentiation, many are either members of a miRNA seed family and/or present in 
multiple copies in the genome. CRISPR/Cas9-mediated KO was therefore unsuited for 
these. Thus, I generated homozygous deletions for 23 miRNAs including candidates with 
up to four locations in the mouse genome. I additionally included in this set a few 
miRNAs for which I measured the affinity using their changes in activity during 
differentiation. This provided an independent validation of the measured miRNA affinity. 
 
 
Figure 25: Knock out based miRNA affinities. 
miRNA affinities of 23 conserved mouse miRNAs are plotted over their respective miRNA 
expression levels in mouse tissues (RPM: reads per million mapped reads). 
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In order to determine how miRNA affinity depends on miRNA expression levels, 
miRNA affinities of 23 KO cell lines were plotted over their respective miRNA 
expression levels (Figure 25). The result shows that miRNA affinity is negatively 
correlated with miRNA expression levels. This result confirms previous findings that 
lowly expressed miRNAs can be as potent or even more potent then highly expressed 
ones. Moreover, it indicates that miRNA affinities can span several orders of magnitude 
which was previously unknown. 
In order to have a complete picture of experimentally determined miRNA 
affinities, I listed all of them in the following table. Of note, miRNA candidates are 
ordered alphabetically and high miRNA potency is denoted by low affinity values. 
Table 2: miRNA affinities.  
miRNA Affinity miRNA Affinity miRNA Affinity miRNA Affinity 
let-7a-5p 122114 miR-134-5p 24597 miR-218-5p 31080 miR-421-3p 806 
miR-1a-3p 5849 miR-136-3p 2767 miR-219-5p 2964 miR-433-3p 757 
miR-7a-5p 69423 miR-136-5p 1086 miR-221-3p 1033 miR-448-3p n.d. 
miR-9-5p 9844 miR-137-3p 59 miR-223-3p 81 miR-450a-5p 12113 
miR-15a-5p 2055 miR-138-5p 1978 miR-224-5p 3523 miR-451a 127 
miR-18a-5p 372 miR-141-3p 2 miR-292-5p 471839 miR-455-5p 1568 
miR-19a-3p 11406 miR-143-3p 29078 miR-293-3p 81416 miR-486-5p 326 
miR-21a-5p 53755 miR-144-3p 126 miR-301a-3p n.d. miR-487b-3p 2652 
miR-22-3p 7096 miR-145a-5p 463 miR-302c-3p 40 miR-488-3p 168 
miR-23a-3p 1184 miR-148a-3p 105271 miR-324-5p 61 miR-490-3p 71 
miR-24-3p 1022 miR-149-5p 447 miR-328-3p 1003 miR-491-5p n.d. 
miR-26a-5p 332 miR-150-5p 1331 miR-330-5p 72 miR-495-3p 3199 
miR-27b-3p 3738 miR-153-3p 32 miR-335-5p 41798 miR-496a-3p n.d. 
miR-30c-5p 224441 miR-155-5p 428 miR-338-3p 25 miR-499-5p 57 
miR-31-5p 913 miR-181a-5p 5406 miR-339-5p 200370 miR-503-5p 438 
miR-33-5p ND miR-184-3p 80 miR-340-5p 2110 miR-504-5p 23 
miR-96-5p 416 miR-186-5p 1543 miR-342-3p 1551 miR-505-3p 26 
miR-99b-5p 1362 miR-187-3p 383 miR-361-5p 695 miR-542-3p 965 
miR-101b-3p 5982 miR-190a-5p 547 miR-365-3p 81 miR-543-3p 3972 
miR-103-3p 53659 miR-192-5p 240 miR-370-3p 235 miR-544-3p 13 
miR-122-5p 12434 miR-193b-3p n.d. miR-375-3p 8080 miR-551b-3p n.d. 
miR-124-3p 819 miR-194-5p 951 miR-376b-3p 270373 miR-590-3p n.d. 
miR-124-5p 1352 miR-196a-5p 1760 miR-376c-3p 944 miR-592-3p n.d. 
miR-125a-3p 370005 miR-199a-5p 6483 miR-377-3p 439 miR-615-3p 11 
miR-125a-5p 370005 miR-200b-3p 9699 miR-378c 2856 miR-653-3p n.d. 
miR-126a-3p 2011 miR-202-3p n.d. miR-379-5p 11117 miR-873b n.d. 
miR-127-3p 251420 miR-208b-3p 66 miR-383-5p n.d. miR-875-5p n.d. 
miR-128-3p 7437 miR-214-3p 645 miR-384-3p 201 miR-876-5p n.d. 
miR-129-5p 8409 miR-216a-5p 302 miR-410-3p 4387   
miR-132-3p 89 miR-216b-3p n.d. miR-411-3p 51036   
miR-133b-3p 691 miR-217-3p n.d. miR-411-5p 331106   
n.d. = not detected (no miRNA expression levels in mouse tissues) 
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4  DISCUSSION 
MicroRNAs act as key players in stem cell homeostasis and cell fate decisions (Bartel et 
al. 2004; Ong et al. 2015). They fine tune gene expression programs on the post-
transcriptional level (Sevignani et al. 2006) and can therefore be seen as an additional 
regulatory layer during cell fate commitment (Ishikawa et al. 2017). Current studies 
extrapolate miRNA activity from miRNA expression levels using large RNA-Seq 
datasets (Li et al. 2018; Castel et al. 2018). However, miRNA activity cannot be inferred 
from expression analysis alone, since the bottleneck of miRNA activity is Ago loading 
rather than miRNA expression (Hausser et al. 2014). In addition, the presence of a given 
miRNA does not prove discernable activity since the 3’UTR of a potential target mRNA 
might not be accessible (Szostak and Gebauer 2013). Thus, miRNA expression studies 
do not yield meaningful insights into miRNA activity or miRNA target regulation. In 
addition to miRNA activity, miRNA affinity is currently underrepresented in the field of 
RNA biology. miRNA affinities are mostly predicted based on miRNA sequences in 
addition to the number of complementary sites in the 3’UTR of potential target mRNAs, 
without experimental validation of miRNA binding or determination of miRNA affinities. 
Since hundreds of miRNAs have overlapping target mRNAs, I postulate that conserved 
miRNAs might differ in their individual potency. In order to better understand general 
aspects of miRNA biology, such as miRNA activity dynamics or miRNA affinity, my 
PhD project aimed to determine single cell miRNA activity dynamics upon mouse 
embryonic stem cell differentiation in addition to miRNA affinity in vivo. This will 
provide a comprehensive picture of the miRNA complement upon mESC differentiation 
in addition to currently understudied miRNA affinities. 
 
4.1  Reporter Assays to experimentally study miRNA activity  
In-silico target predictions and experimental approaches are currently the two ways to 
study miRNA activity. In-silico approaches utilize bioinformatic target prediction tools 
such as TargetScan (Lewis et al. 2003), miRanda (Enright et al. 2003; John et al. 2004), 
PicTar (Lall et al. 2006), or miTarget (Kim et al. 2006) among others. Those tools, 
however, predict inconsistent miRNA targets overrating some miRNA-to-target 
interactions and underrating others (Lewis et al. 2003; Watanabe et al. 2007). Since 
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miRNAs can regulate multiple targets, prediction tools result in lists of mRNA targets, 
however, some of them might be false positive. Therefore, I decided to follow an unbiased 
experimental approach of studying the miRNA dynamics of all broadly conserved 
miRNAs among vertebrates upon mESC differentiation. This approach resulted in a list 
of 162 miRNA candidates present in the mouse genome. 
Pioneering research in the field of miRNA:mRNA interactions established 
multiple techniques to characterize miRNA to target interaction ranging from qRT-PCR, 
western blot, immunoprecipitation of active RISC complexes with HITS-CLIP (Chi et al. 
2009), tandem affinity purification of miRNA target mRNAs (TAP-tar) (Nonne et al. 
2009), biotinylated synthetic miRNAs that bind potential mRNA targets (Ørom and Lund 
2007) to luciferase reporter assays (Clément et al. 2015). All approaches have in common 
that they are invasive and destroys the history of a given sample. Moreover, none of these 
techniques are unbiased in their candidate choice, hence, the target mRNA or miRNA of 
interest needs to be known and decided on before characterization. 
miRNA activity studies largely focused on luciferase reporter gene assays which 
are quantitative and determine the silencing of a possible target gene by a specific miRNA 
(Clément et al. 2015). This strategy relies on the ectopic expression of the predicted 
miRNA target cloned downstream of a luciferase reporter in addition to overexpression 
of the miRNA of interest, which does not mimic physiological levels. Therefore, I used a 
single cell ratiometric reporter, developed in our lab, which corrects for locus specific 
transcriptional noise by expressing a normalizer (mCherry) and miRNA sensor (Citrine). 
The reporter was designed as such that a perfectly complementary miRNA target site was 
cloned downstream of the miRNA sensor. The previous PhD student in the lab could 
validate that the endogenous pool of miR-142-3p molecules was not titrated by “citrine-
sensor-bait molecules” over a 20-fold transgene expression range. Therefore, my 
approach does not face any miRNA sponging effects (Sladitschek and Neveu 2015b).  
 
4.2  miRNA seed drives target mRNA recognition 
miRNAs interact with their target mRNAs in a sequence specific manner. Mature 
miRNAs are loaded onto Ago proteins which results in the biologically active RISC 
complex. RISC specifically binds miRNA regulatory elements (MREs) in the 3’UTR of 
their target mRNAs. However, the regulatory interaction of miRNAs and its target seems 
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to be rather complex and is therefore poorly understood. It is well accepted in the field 
that target mRNAs are either transcriptionally repressed or degraded, depending on the 
degree of miRNA to target complementarity and depending on the interaction of the 
functional miRNA domains (anchor, seed, 3’ region) with its respective Ago protein. In 
this study, I determined the impact of the seed sequence (nt 2-8) on target mRNA 
specificity. This was of interest because recent studies propose the impact of miRNA 
domains beyond the seed sequence (5’- and 3’-region) on target binding. (Grimson et al. 
2007; Broughton et al. 2016). Moreover, structural insights into Ago bound miRNAs 
revealed that Ago subdivides its loaded miRNA guide into distinct functional parts that 
changes target binding properties compared to naked miRNAs (Wee et al. 2012). 
To address this question, I generated two scrambled miRNA reporter versions for 
miR-136 and compared its miRNA activity to the full-length complementary control 
(Figure 11). The first scrambled construct was composed of a fully scrambled miRNA 
target sequence. As expected, this reporter cell line showed no sensor regulation upon 
miR-136 expression. The second scrambled miRNA reporter was composed of a 
functional seed binding region (nt 2-8) in an otherwise fully scrambled miRNA target 
sequence (scrambled 5’- and 3’region). Comparing the miRNA activity data of the “seed 
only” construct to its unedited control showed, that the seed sequence is indeed the main 
driver of target recognition. Strikingly, the seed-only reporter did exert almost equal 
miRNA activity compared to its full-length miRNA control. This confirms, that the 
miRNA seed alone is sufficient to regulate its target mRNA. This finding is in line with 
biochemistry studies showing that Ago2 masks functional miRNA domains apart from 
the seed sequence in order to display the seed in a pre-helical structure (Klein et al. 2017). 
This specific 3D arrangement lowers the entropic barrier to target binding and speeds up 
the target search process (Klein et al. 2017). Intriguingly, seed-only matched and full-
length complementary miRNAs were found to associate and dissociate from respective 
mRNA targets at similar rates (Wee et al. 2012). Which confirms that the seed sequence 
is sufficient for target repression in mammals, as opposed to flies, where only full miRNA 
complementarity results in target cleavage (Wee et al. 2012).  
Exposing only the seed sequence on the surface of functional RISC while other 
functional domains are hidden by Ago does explain the miRNA crosstalk I encountered 
in my miRNA activity screen. The seed sequence of miR-295 and miR-302b did overlap 
perfectly. Thus, the reporter cell line for miR-302b recapitulated the miRNA activity 
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profile of the miR-295 reporter cell line. This result was unexpected as miRNA 
expression levels suggested the upregulation in miR-302b activity levels. In order to 
measure miRNA activity for the miR-302 cluster, I identified miR-302c with its non-
overlapping and unique seed sequence as representative of the cluster and repeated the 
activity measurements. Results of the miR-302c reporter cell lines showed the expected 
upregulation of miR-302 activity during endoderm differentiation. Taken together these 
results show, that miRNA activity can only be measured for unique miRNA sequences. 
Moreover, it visualizes that overlapping seed sequences are key to regulate multiple 
mRNA targets. 
 
4.3  miRNAs in pluripotent state 
Distinct miRNA signatures such as miR-106a, miR-200, miR-142 or miR-290 were 
shown to be crucial for stem cell pluripotency (Lichner et al. 2011; Sladitschek and Neveu 
2015b; Balzano et al. 2018). In order to validate that the miRNA sensor faithfully 
measures temporal changes of miRNA activity in pluripotency, I designed the miR-295-
3p sensor. The miR-290 cluster comprises seven mature miRNAs (Yuan et al. 2017) 
which have been shown to be implicated in pluripotency by negatively regulating Dkk-1, 
a known Wnt path inhibitor (Zovoilis et al. 2009), or Rbl2, a known epigenetic 
transcriptional repressor (Sinkkonen et al. 2008; Benetti et al. 2008). In order to 
differentiate, stem cells need to silence pluripotency programs and activate differentiation 
gene programs. Thus, miR-290 cluster expression levels are downregulated upon mESC 
differentiation (Lichner et al. 2011). I postulate that due to the decline of miRNA 
expression levels, also miR-295 activity should be downregulated. Indeed, I could show 
that miR-295 activity declines in all three major germ layers (Figure 12) upon 
pluripotency exit.  
In addition to pluripotency associated miRNAs, I screened the deep sequencing 
dataset for heterogeneously expressed miRNAs in pluripotent state. Surprisingly, the 
dataset revealed miR-21a, which is known to have functional roles in development, 
cancer (Kumarswamy et al. 2011) and mesenchymal stem cell differentiation (Sekar et 
al. 2015) but not pluripotency. I hypothesize, that miR-21a might have functional role in 
pluripotency, similar to transcription factor heterogeneity (Torres-Padilla and Chambers 
2014). miRNA heterogeneity might open a “window of opportunity” for external stimuli 
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that trigger pluripotency exit. This hypothesis is fostered by the finding that high miR-
21a expression levels coincide with low Nanog expression levels (Figure 14). Nanog was 
previously shown to be heterogeneously expressed in mESCs (Singh et al. 2007), which 
allowed embryonic stem cells to explore pluripotency (Abranches et al. 2014). 
Interestingly, Nanoglow cells were found to be prone to differentiate whereas Nanoghigh 
cells kept the pluripotent state (Singh et al. 2007). These findings are in line with genetic 
ablation studies of Nanog which triggered differentiation of mESCs towards a primitive 
endoderm fate, whereas Nanog overexpression enhanced stem cell self-renewal 
(Chambers et al. 2003; Mitsui et al. 2003). I propose that similar regulatory effects might 
be possible for miR-21a, where miR-21ahigh cells are prone to differentiate and miR-
21alow cells continue to self-renew. Such potential regulatory effects would need further 
investigation which is beyond the scope of this thesis project. 
 
4.4  miRNAs in differentiation 
In addition to crucial roles in pluripotency, miRNAs regulate differentiation by fine 
tuning gene expression programs (Michaels et al. 2019). Subtle changes in gene 
expression have been shown to be sufficient to prime stem cells for differentiation (Yu et 
al. 2012). Intriguingly, miRNAs promote the transition from self-renewal to 
differentiation by suppressing pluripotency programs and activating differentiation 
genes. miR-200c, miR-203, and miR-183, for instance, cooperate to repress Sox2 and 
Klf4 (Wellner et al. 2009), which facilitates pluripotency exit and onset of differentiation. 
Pioneering work on miRNA expression levels in terminally differentiated cells has added 
valuable knowledge to the understanding of differentiation. miR-1 and miR-133 clusters, 
for instance, are highly expressed in mESCs regulating the differentiation towards cardiac 
muscle cells (Ivey et al. 2008; Tao et al. 2015). Furthermore, miR-214 has been shown to 
target Ezh2, a polycomp group protein that occupies and represses promoters of 
mesoderm differentiation genes among others. However, one has to keep in mind that 
miRNA research is largely based on sequencing datasets that reflect the population 
average of millions of cells, thus, potentially masks subtle changes in miRNA expression. 
Therefore, my miRNA activity dataset utilizes single cell resolution data which adds 
resolution to previously unrecognized subtle changes in miRNA activity. 
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This thesis project studied the temporal regulation of miRNA activity upon mESC 
differentiation on a global scale rather than focusing on specific miRNA candidates. I 
could show that miRNAs conserved among mammals are tightly regulated in their 
temporal miRNA activity profile. Moreover, I find that miRNAs can be classified into 
early, mid and late regulators of differentiation. Interestingly, most of the conserved 
miRNAs were upregulated throughout all germ layers, yet, their temporal profile differed 
vastly between mesoderm, endoderm and ectoderm lineage (Figure 18). This tight 
temporal regulation might either be crucial for cell fate commitment or for keeping cells 
in the trajectory they decided on. Strikingly, principle component analysis on miRNA 
activity could distinguish different fate choices (Figure 19). Divergence in miRNA 
profiles occurred already 48 hours after onset of differentiation, where each germ layer 
followed a specific trajectory. Surprisingly, once a cell has decided for its trajectory, it 
does not switch fate anymore. I postulate, that this tight temporal regulation of miRNA 
activity helps to keep differentiating cells on their committed trajectory. This finding is 
in line with Waddington’s concept of “progressive restriction of cell differentiation 
potential during normal development” (Ladewig et al. 2013, p1).  
Furthermore, my study shows miRNA activity of RISC loaded complexes in 
mESC differentiation for the first time. The data suggest that miRNA activity is very 
dynamic upon differentiation of stem cells, suggesting that miRNAs are another class of 
important regulators in facilitating the transition from pluripotency to differentiation 
programs by poising naïve cells for differentiation. Surprisingly, most conserved 
miRNAs were regulated at least in two or all three germ layers. This suggests that the 
majority of conserved miRNAs regulate differentiation in a cooperative manner rather 
than being germ layer specific, which does not exclude single miRNA clusters from being 
germ layer specific. Indeed, miRNA expression levels of differentiated mESCs suggest 
the miR-302 cluster to be endoderm specific.  
The miR-302 cluster resides in an intron of the LARP7 gene and is encoded as 
single polycistronic transcriptional unit. The cluster is highly conserved among 
vertebrates and consist of five members: miR-302a, b, c, d and miR367 (Barroso et al. 
2008; Chen et al. 2015). I could show that all members of the cluster are upregulated 
solely in endoderm but not mesoderm or neuroectoderm lineage (Figure 15). miR-302 is 
believed to repress AKT target genes and upregulate MEK expression, which in turn 
promotes differentiation of stem cells (Gu et al. 2016). In order to validate the necessity 
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if miR-302 expression for endoderm differentiation one would need a functional test. I 
developed a Sox17-H2B Citrine reporter cell line that marks the successful differentiation 
towards the endoderm lineage. This reporter cell line could be used for gain- and loss-of-
function experiments of the miR-302 cluster in order to determine its necessity for 
endoderm specification. This approach, however, might be challenging due to miRNA 
redundancy. Preliminary results from my project showed that homozygous KO of miR-
302c did not impair endoderm differentiation (data not shown). This suggests that other 
miRNAs of the cluster might buffer the miR-302c loss. The next step would be to KO the 
entire miR-302 cluster in order to screen for phenotypic effects in the Sox17 fate marker 
line. Interestingly, characterization of the miR-290 cluster in studies reported elsewhere 
faced similar obstacles. Only the KO of the entire miRNA cluster but not single members 
blocked pluripotency programs (Gu et al. 2016). Taken together, these results show that 
miR-302 expression is endoderm specific. However, the functionality of this finding 
requires further validation by gain- and loss-of-function experiments which were beyond 
the scope of this thesis project. 
 
4.5  Developmentally important miR-17/92 and miR-379/410 
cluster 
Genomic manipulation of the miR-17/92 cluster revealed its pivotal role in fine-tuning 
signaling cascades and developmental pathways (Concepcion et al. 2012) throughout 
normal mouse development (Lu et al. 2007; Ventura et al. 2008). I could show that the 
affinity of the miR-17/92 cluster is overall upregulated upon mESC differentiation, which 
hints to a functional role in mESC differentiation. Interestingly, miR-17 is known to 
directly target the TGF-ß receptor II, whereas miR-18a targets SMAD2 and SMAD4 
(Mogilyansky and Rigoutsos 2013). SMAD proteins are members of the TGF-
ß/Nodal/Activin signaling pathway, with pivotal role in stem cell specification (Liu et al. 
2018). These findings manifest the hypothesis that miR-17/92 cluster might be pivotal 
for mESC differentiation. 
Interestingly, the temporal regulation of specific members of the miR-17/92 
cluster differs among the three-germ layers. miRNA activity of miR-17 and miR-18, for 
instance, was upregulated from day 2 of mesoderm differentiation whereas the same 
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miRNAs were upregulated earliest by day 4 in the endoderm lineage (Figure 16). This 
suggests that the temporal profile of miRNA activity might be important in order to 
facilitate or maintain the right cell fate. It is of note that miRNA activity of all cluster 
members is not equally upregulated within a given germ layer. This suggests that either 
single miRNAs of the cluster are more important than others to the specific germ layer, 
or miRNA biogenesis is not equally efficient for all cluster members. miR-17/92 
biogenesis studies found that the pri-miR-17/92 polycistronic transcript folds into a 
complex tertiary structure with solvent exposed and solvent-advert domains. This folding 
leads to sequential processing of the individual cluster members depending on 
microprocessor accessibility (Chaulk et al. 2011). Therefore, the pri-miR structure results 
in an autoinhibitory conformation in embryonic stem cells (Du et al. 2015) which explains 
why some members of the cluster are processed more efficiently than others. The germ 
layer specific differences in miRNA activity of cluster members are therefore probably 
explained by differences in miRNA biogenesis, as the expression levels do not correlate.  
Another developmentally important cluster is the miR-379/410 cluster, which is 
the largest known placental mammal-specific miRNA cluster, and located in the Dlk1-
Dio3 locus. The cluster comprises 40 miRNAs out of which 27 are represented in the 
miRNA activity dataset (Figure 17). Interestingly, only miRNAs from the maternal allele 
were found to be expressed (Labialle et al. 2014). Moreover, correct dosage of the Dlk1-
Dio3 locus has been shown to be crucial for embryonic growth and neuronal development 
(Rocha et al. 2008). However, the biological importance of the miRNA cluster remains 
elusive. It might be implicated in physiological processes such as embryonic growth or 
placental and neuronal development (Labialle et al. 2014; Rocha et al. 2008).  
Similar to miR-17/92, the miR-379/410 cluster activity is upregulated throughout 
differentiation, which suggests a cooperative effect. I could further show, that miR-
379/410 activity cannot be inferred from miRNA expression analysis, as miRNA 
expression levels show a different temporal profile than miRNA activity data. Moreover, 
elevated expression levels do not necessarily result in elevated miRNA activity 
(Figure 17). Interestingly, Hausser et al. could show that the bottleneck of miRNA 
activity is Ago loading rather than miRNA expression (Hausser et al. 2014), which fosters 
the hypothesis that miRNA expression levels are not sufficient to give insights into 
miRNA activity. Pioneering work on miRNA sensors and decoy libraries showed that 
60 % of miRNAs detected by deep-sequencing had no discernible activity (Mullokandov 
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et al. 2012). Therefore, miRNAs expressed below ~ 100 copies per cell had no or little 
regulatory activity (Brown et al. 2007). These and other results suggest that the functional 
‘miRNome’ of a cell is considerably smaller than currently assumed from miRNA 
expression studies. Taken together, my data suggest that the temporal regulation of 
miRNA activity might have a crucial role in stem cell differentiation. The impact of miR-
379/410 cluster on differentiation efficiency, however, would need to be further assessed 
by gain- and loss-of-function experiments in fluorescently labeled fate marker cell lines 
that I established for all major germ layers. Of note, KO experiments of the miR-379/410 
cluster in mice aimed to elucidate the biological role of this cluster and showed that 
neonates deficient for miR-379/410 failed to maintain energy homeostasis and died 
shortly after birth (Labialle et al. 2014). This was one of the first demonstrations that 
miRNAs exert critical functions in the temporal activation of metabolic genes in the 
newborn’s liver (Labialle et al. 2014) and highlights the importance of this miRNA 
cluster. 
 
4.6  miRNA affinity and miRNA activity in mESCs 
The mammalian genome encodes thousands of miRNAs, therefore, it is highly likely that 
not all of them are equally potent. The miRNA biology field is currently lacking detailed 
insights into basics of miRNA potency. This study finds, that miRNA potency is not 
dependent on miRNA expression levels. Furthermore, my results indicate that weakly 
expressed miRNAs can be as potent as highly expressed ones (Figure 20), which can 
probably be explained by differences in their respective miRNA affinity. As miRNA 
affinity determines the decay kinetics of target proteins (Breda et al. 2015), it is of interest 
to elucidate miRNA-levels, - activity and – affinity in order to better understand 
molecular basics of stem cell differentiation. 
miRNA affinity is often predicted based on the miRNA sequence using various 
bioinformatic programs that apply free-energy prediction (∆G) thermodynamic 
calculations (Sethupathy et al. 2006). However, these calculations do not reflect miRNA 
affinities under physiological conditions. Therefore, I plotted predicted base pair energies 
for both, full-length seed (nt 2-8) and sub-seed (nt 2-4) sequences over their respective 
experimentally determined miRNA-to-target affinities measured in my screen. The data 
revealed, that miRNA affinities are not correlated to base pairing energies. Therefore, 
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miRNA affinities cannot be predicted but need to be experimentally determined. miRNA 
affinity prediction methods have many pitfalls as they disregard the fact that the minority 
of expressed miRNAs are biologically active (Mullokandov et al. 2012). Moreover, they 
predict miRNA affinity based on full length miRNA to target complementarity although 
miRNAs largely bind their targets through partial sequence complementarity over a short 
sequence (Grimson et al. 2007). In addition, prediction tools treat miRNAs as naked RNA 
molecules, yet, Ago2 has been shown to change nucleic acid properties by making them 
behave more like an RNA-binding protein, rather than a free RNA (Salomon et al. 2016). 
In vitro binding kinetics for Ago bound let-7a, for instance, were 43-fold faster than for 
let-7a alone (Salomon et al. 2016). This shows that miRNA affinities need to be 
experimentally determined. 
 
 
Figure 26: miRNA affinities are not correlated to predicted base pairing energy. 
Free energy predictions (∆G) for full-length seed (nt 2-8) and sub-seed (nt 2-4) were plotted 
over their respective miRNA affinities derived from my dataset. 
 
This study aimed to experimentally determine miRNA affinities of 162 conserved 
miRNAs in mESCs. Calibration of the miRNA reporter (Figure 21) revealed that miRNA 
activity depends on both, miRNA expression and miRNA affinity. Thus, miRNA activity 
gives direct access to miRNA affinity. I postulate that the dependence of the miRNA 
detector levels D on the miRNA concentration M followed a Hill’s equation with non-
cooperative binding, where K (affinity) is the binding constant and n is the Hill coefficient 
of the interaction. With this assumption I could calculate the affinity of conserved 
miRNAs following two strategies, direct (miRNA KO cell lines) and indirect 
Affinities are not correlated to the base pairing energy
0
-5
-10
-15
Pr
ed
ict
ed
 Δ
G 
se
ed
 p
air
ing
 (k
ca
l.m
ol-
1 )
miRNA-target KD (a.u.)
10010-310-6
0
-1
-2
-3
Pr
ed
ict
ed
 Δ
G 
nt
 2
-4
 p
air
ing
 (k
ca
l.m
ol-
1 )
miRNA-target KD (a.u.)
10010-310-6
-4
-5
-6
-7
-8
4 DISCUSSION 
 71 
(∆	expression method) miRNA affinity measurement. Affinities derived from the ∆	expression method rely on an integrative approach of miRNA expression levels and 
miRNA activity data from differentiated mESCs. Adjustment of detector mRNA 
expression levels as a function of miRNA expression levels with Hill's equation enabled 
me to derive the affinity for 96 conserved miRNAs (Figure 23). This method is new to 
the field and enables previously uncharacterized miRNA affinity measurement in vivo. 
Of note, miRNAs not changing in the expression-based approach due constitutively 
active miRNAs or absence of miRNA expression, would prevent the computation of the 
miRNA affinity. Therefore, I developed an alternative approach using miRNA KO 
reporter cell lines.  
The direct miRNA affinity measurement relies on the homozygous miRNA KO 
within its respective miRNA reporter cell line (Figure 24). I generated CRISPR/Cas9 KO 
cell lines for 23 randomly picked miRNAs and could show, that miRNA affinity is 
negatively correlated with miRNA expression levels. Moreover, my data reveal that 
weakly expressed miRNAs can be as potent or even more potent then highly expressed 
ones. In addition, the results indicate that miRNA affinities span several orders of 
magnitude, which was previously unknown. Strikingly, miRNA affinities of let-7 and 
miR-21 measured in my project are comparable with previous studies from Salomon and 
colleagues. Ago2 bound let-7 was reported to be 3-fold more potent than miR-21 
(Salomon et al. 2016) which is comparable to a 2,3 fold difference measured in my 
affinity experiments. Taken together my dataset suggests, that conserved miRNAs differ 
in their respective potency due to differences in miRNA affinity. 
So far experimental studies on miRNA affinity relied on purified Ago2-RISC 
which was used in filter-binding assays or single-molecule FRET assays using total 
internal reflection fluorescence microscopy (Wee et al. 2012; Chandradoss et al. 2015). 
Stochiometric titration showed that one mouse Ago2-miRNA molecule bound one target 
molecule at a time. Strikingly, direct binding assays did not find substantive differences 
in miRNA affinity for full miRNA complementarity versus seed only binding (Wee et al. 
2012), which confirms results found in my study. Wee and colleagues further subdivided 
the miRNA and seed sequence into separate functional parts. They could show that central 
(nt 10-11) and terminal nucleotide mismatches (nt 20-21) had no detectable effect on 
target binding. Strikingly, mismatches within the seed sequence (nt 4-5), however, 
reduced target binding by 40-fold (Wee et al. 2012). This suggests, that the miRNA seed 
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sequence determines miRNA affinity and activity. Similar results were obtained from 
single-molecule FRET sensors which fosters the notion that miRNA seed sequence 
determines target finding, binding and silencing (Chandradoss et al. 2015; Salomon et al. 
2016). Of note, there are additional factors influencing miRNA activity such as miRNA 
half-life (up to 72 hours) (Baccarini et al. 2011; Krol et al. 2010) and target mRNA 
concentration (Baek et al. 2008). Moreover, low levels of miRNA expression can still 
result in high miRNA activity since miRNA molecules are recycled (Baccarini et al. 
2011) and one miRNA molecule per target mRNA is sufficient to facilitate target 
repression (Filipowicz et al. 2008) 
Interestingly, target mRNAs have been shown to affect miRNA activity in a 
bidirectional control mechanism. Either by the competing endogenous RNA (ceRNA) 
(Thomson and Dinger 2016) or the target-directed miRNA degradation mechanism 
(TDMD) (Rüegger and Großhans 2012). The ceRNA hypotheses postulates that 
endogenous transcripts with shared miRNA binding sites compete for translational 
control. Therefore, expression changes in competing targets might influence miRNA 
activity on other targets since the upregulated endogenous target acts as miRNA sponge 
(Salmena et al. 2011). A similar hypothesis was proposed from Brown and colleagues 
(Brown et al. 2006) suggesting that discernable miRNA activity is only present when 
> 100 miRNA copies are expressed per cell.  
The TDMD mechanism on the other hand postulates that the RNA target 
facilitates degradation of its miRNA (Bitetti et al. 2018). This process is accompanied by 
miRNA sequence modifications such as tailing (nt addition), trimming (nt shortening) 
(Ameres et al. 2010) or unloading from Ago (De et al. 2013), which would disrupt the 
active RISC complex. Indeed, both hypotheses are interesting and would explain how 
miRNA activity is modulated. Yet, they need further validation as they are highly debated 
in the field. Wee and colleagues for instance challenge this hypothesis by proposing that 
competitive mechanisms might only impact weakly expressed miRNAs. Highly abundant 
miRNAs, will not be regulated by seed-matched competitor transcripts (Wee et al. 2012) 
simply because the number of competitor targets would comprise 12 % - 50 % of all 
miRNAs in the cell (Islam et al. 2011). Therefore, highly abundant miRNAs are not 
affected by the two mechanisms described. 
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4.7  Outlook and Future Experiments 
This PhD project determined the miRNA activity dynamics in mESC differentiation and 
miRNA to target affinity for 119 conserved miRNAs in vertebrates. The next step would 
be to identify key miRNAs or miRNA clusters, pivotal for stem cell differentiation on a 
global level (multilineage priming) or germ layer specification. miRNAs could be ranked 
according to their effective potency. Promising candidates would then be subject to gain- 
and loss-of-function experiments in fate marker cell lines that I have established in order 
to validate their functionality. Once miRNAs with phenotypic effects in germ layer 
specification were identified, one could investigate miRNA targets and underlying 
signaling cascades of mESC differentiation. 
miRNA functionality is validated by measuring the efficiency of stem cell 
differentiation towards their respective fate, using fluorescently labeled fate marker cell 
lines that I established. Site directed homology recombination was used to place the 
coding sequence of fluorescent protein H2B-Citrine under the endogenous promoter 
driving the expression of Sox17 (endoderm), Vimentin (mesoderm) and Tubb3 
(neuroectoderm), in independent cell lines. Once expressed, H2B-Citrine localizes in the 
nucleus where it is stabilized due to its H2B part. Differentiation of such fate marker cell 
lines towards their respective fate while measuring Citrine expression in confocal analysis 
or flow cytometry, would be the readout for the functionality test.  
In a preliminary experiment I differentiated all three fate marker lines towards 
their respective germ layer and analyzed Citrine expression using confocal analysis 
(Figure 27). In order to validate the correct temporal expression of citrine, I co-stained 
well characterized fate marker proteins for each germ layer using immuno-fluorescence. 
Fate marker FoxA2 (endoderm), Vimentin (mesoderm) and Tubb3 (ectoderm) were 
identified from literature and AB-stained according to manufacturer’s recommendation. 
Immunofluorescence showed that the fluorescent sensor is co-expressed with its 
respective fate marker in the correct temporal order. 
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Figure 27: Confocal analysis of differentiated fate marker cell lines. 
mESCs were differentiated towards the endoderm, mesoderm and neuroectoderm lineage. 
The fate specific H2B-Citrine reporter is expressed under the endogenous promoter of its 
respective fate marker gene: Sox17 (endoderm), Vimentin (mesoderm) and Tubb3 
(ectoderm). Temporal expression of the fluorescent fate marker sensor was validated by 
immunofluorescence of well-established fate marker proteins: FoxA2 (endoderm), Vimentin 
(mesoderm) and Tubb3 (ectoderm). Scale bar is 50 µm. 
 
Since immunofluorescence is laborious, expensive due to AB labeling and yields 
no live cell data, fluorescently labeled fate marker cell lines are the perfect alternative to 
allow stem cell differentiation over extended periods of time while tracking the temporal 
expression of their respective fate marker in live cells. Therefore, I used flow cytometry 
analysis which allows the measurement of millions of live cells in single cell resolution 
while being more cost efficient then confocal analysis (Figure 28). Intriguingly, 
differentiation of mESCs towards the three major germ layers resulted in 38 % positive 
cells for Sox17 (endoderm), 77 % positive cells for Vimentin (mesoderm) and 67 % 
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positive cells for Tubb3 (ectoderm). This result shows, that mESCs can be reliably 
differentiated towards any of the major germ layers. 
 
 
Figure 28: Flow cytometry analysis of fate marker cell lines. 
mESCs were differentiated towards endoderm, mesoderm, ectoderm lineage and analyzed 
via flow cytometry. The H2B-Citrine sensor marks the expression of the corresponding fate 
marker genes: Sox17 (endoderm), Vimentin (mesoderm) and Tubb3 (ectoderm). Histograms 
of cells negative (day 0) and positive (day 7 or day 8) for citrine expression were overlaid 
according to their respective fate. 
 
In addition to the “efficiency of differentiation test”, cells positive for the 
respective fate marker could be subject to FACS sorting and RNA extraction in order to 
study the transitions from pluripotent to differentiated state. Transcriptomics of FACS 
sorted cells might help to delineate the molecular mechanisms that yield mature and 
functional differentiated cell types. 
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5 CONCLUSIONS 
The presented study aimed to determine single cell miRNA dynamics during mouse 
embryonic stem cell differentiation. I established stable mESC lines expressing 
fluorescent reporters for the 162 miRNAs conserved among vertebrates. I could show, 
that the temporal miRNA activity profile is tightly regulated throughout mESC 
differentiation. Interestingly, miRNAs exhibit activity changes at early, mid and late 
stages of stem cell differentiation. Moreover, miRNAs seem to regulate differentiation in 
a cooperative manner on a global level rather than being germ layer specific. Strikingly, 
based on principle component analysis, miRNA activity diverged between germ layer 
fates already at 48 hours after onset of differentiation. 
By integrating measurements of miRNA activity and expression levels, I 
experimentally determined miRNA affinities for the respective reporter construct of 119 
conserved miRNAs. Surprisingly, miRNA affinities can span several orders of 
magnitude. Moreover, miRNA affinities are negatively correlated to miRNA expression 
levels, which suggests that weakly expressed miRNAs can be as potent as highly 
expressed ones. Knowing the affinity and expression levels in a given cell type, enables 
me to rank miRNAs according to their effective potency. This will potentially help to 
determine which genes are targets of a given miRNA. Future gain- and loss-of-function 
experiments of interesting miRNAs in established fate marker cell lines will aid to reveal 
miRNAs indispensable for stem cell differentiation. 
Taken together, this thesis project provides new insights into miRNA dynamics 
and previously understudied miRNA potency in stem cell differentiation at single cell 
resolution. 
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6  METHODS 
6.1  Mouse embryonic stem cell culture 
6.1.1  General preparations before cell culture  
Cell culture grade sterile reagents, plastic ware and glassware was used throughout all 
experiments. Experiments were performed in a laminar air flow hood which was switched 
on and UV-sterilized with the glass front closed for at least 15 min prior to work. The 
“warm up phase” of 15 min ensured a stable air flow. The working surface, in addition to 
any working material that entered the flow hood, was sprayed with 70 % Ethanol and 
wiped clean prior to work. Sterile cell culture plasticware was opened and closed 
exclusively under the laminar air flow. According to good cell culture practice, bottles, 
containers and plates would be closed during the working process whenever possible. 
After finishing cell culture work, the laminar air hood was cleaned and wiped with 70 % 
Ethanol to disinfect the working surface. The germicidal UV-lamp was switched on, with 
the blower running, for at least 15 min after finishing the work. 
Liquid culture materials such as D-PBS, H2O, gelatin, media or any other non-
commercial and as sterile declared solution was autoclaved or sterile filtrated using a 
0,22 µm Stericup Filter Unit (Millipore, SCGPU05RE). Cell culture media was sterile 
filtrated, aliquoted in 500 mL bottles and stored at 4 °C. Media was pre-warmed to 
~ 37 °C in a water bath prior to use. 
Cells were cultured at 37 °C and 5 % CO2 in a humidified incubator. The humidity 
chamber was filled with water on a weekly basis. The inside of the incubator and all its 
stainless steel shelfs were cleaned with 70 % Ethanol once a month. The incubator was 
used for cell culture only after humidity and CO2 levels were equilibrated. 
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6.1.2  Preparation of gelatin coated plates 
0,1 % (w/v) gelatin solution was prepared as follows: 1 g pork gelatin (SIGMA; G1890) 
and 600 mL autoclaved water were added to a sterile 1 L beaker. The solution was swirled 
and microwaved till its boiling point (solution needs to boil to ensure proper solution of 
gelatin in water). The solution was topped up to a final volume of 1 L with H2O (RT). 
After a short cooling period (till liquid reached approx. 50 °C), gelatin was sterile filtered 
in the laminar air hood using a 0,22 µm Stericup Filter Unit (Millipore; SCGPU05RE). 
Gelatin was aliquoted in 1 L bottles and stored at 4 °C. 
Cell culture dishes were coated with 0.1 % gelatin (RT) latest 20 min before the 
experiment. The coating volume was chosen according to the culture volume of the 
respective dish. After checking that the entire dish surface was covered, gelatin coated 
plates were stored in the incubator till used. Prior to performing the experiment, gelatin 
was aspirated and the dish air dried before fresh media was added to the plate. 
6.1.3  mES cell l ines 
All stable transgenic cell lines were derived from AB2.2 cell line (ATCC®SCRC-
1023™). The AB2.2 cell line was regularly karyotyped and tested for mycoplasma 
contamination. 
6.1.4  mESC maintenance and propagation 
Mouse embryonic stem cells (mESCs) were maintained without feeders under standard 
pluripotency conditions in ES complete media (LIF+Serum) (Table 3) on gelatin coated 
plates, and maintained at 37 °C with 5 % CO2 in a humidified incubator.  
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Table 3: ES complete -  media composition. 
Component Comment Supplier (Number) Concentration 
DMEM high glucose, 
w/o glutamine 
Invitrogen (11960) 80 % (v/v) 
Fetal Bovine Serum ES-qualified Millipore (ES-009-B) 15 % (v/v) 
100x Non-Essential 
        Amino Acids 
10 mM glycine 
10 mM L-alanine 
10 mM L-asparagine 
10 mM L-aspartic acid 
10 mM L-glutamic acid 
10 mM L-proline 
10 mM L-serine 
Invitrogen (11140) 1x (100 µM) 
100x L-Glutamine 200 mM Invitrogen (25030) 1x (2 mM) 
100x Sodium Pyruvate 100 mM Invitrogen (11360) 1x (100 µM) 
100x Penicillin- 
        Streptomycin 
10,000U mL-1  
10,000U mL-1 
Invitrogen (15140) 1x (100 U mL-1 
Pen./Strep.) 
2-Mercaptoethanol 55 mM in D-PBS Invitrogen (21985) 100 µM 
Murine LIF Recombinant EMBL PEPCore 10 ng/mL 
 
The media was sterile filtrated using a 0,22 µm Stericup Filter Unit (Millipore; 
SCGPU05RE) and aliquoted in 500 mL bottles with subsequent storage at 4 °C. ES 
complete media was changed daily, whereas mESCs were passaged every other day. Cell 
dilution for passaging was chosen as such that the culture reached ~ 80 % confluency on 
the day of passaging. Cell culture media was replaced 2-3 hours before splitting cells. 
Prior to passaging, cells were washed with D-PBS (2,7 mM KCL, 1,47 mM KH2PO4, 
137 mM NaCl, 8,1 mM N2HPO4, pH 7,4) (RT). Subsequently, 0,05 % Trypsin-EDTA 
solution (Invitrogen, 25300) was added in a dropwise manner (~ 20 µL/cm2) to cover the 
entire surface of the well. Trypsin was incubated for 5 min at 37 °C. Trypsin was 
inactivated by addition of ES complete media (volume was chosen according the 
respective plate volume). Single cell suspension was generated by pipetting the cell 
suspension 10-15 times, while flushing the surface of the well. 50 µL of the cell 
suspension was diluted in 50 µL of 0,4 % (w/v) Trypan blue (Invitrogen, 15250) and cells 
were counted using a hemocytometer (Neubauer improved chamber). Cell viability was 
expected to be ≥ 98 %. Pre-prepared gelatin coated plates were aspirated, and fresh ES 
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complete media (37 °C) was added to the dish before cells were seeded at a density of 
~ 40,000 cells/cm2 and incubated at 37 °C with 5 % CO2 in a humidified incubator. 
6.1.5  Freezing mouse embryonic stem cells  
Cells to be frozen had reached ~	80 % of confluency with a cell viability of ≥ 98 %. 
Culture media was changed 2-3 hours before freezing cells. Cells were washed with D-
PBS (RT) before adding 0,05 % Trypsin-EDTA solution (Invitrogen, 25300) in a 
dropwise manner (~	20 µL/cm2) to cover the entire surface of the well. Trypsin was 
incubated for 5 min at 37 °C and inactivated by addition of ES complete media 
(inactivation volume according to culture volume of the respective dish). Single cell 
suspension was achieved by pipetting the cell suspension 10-15 times while flushing the 
surface of the well. The entire cell suspension was transferred to a labeled and sterile 
15 mL falcon. Cells were spun down (5 min, 500 rpm, RT), the supernatant was removed 
and the cell pellet resuspended in 1 mL (from a 6 well) of freezing media (10 % DMSO 
(v/v) (SIGMA, D8418) in ES-qualified EmbyroMax Fetal Calf Serum (Millipore, ES-
009-B)). The cell suspension was transferred to a cryo-vial (1 mL per vial) and cryo-vials 
were placed in a polystyrene sandwich at - 80 °C, overnight. Cryo-vials were transferred 
to liquid nitrogen for long-term storage. 
6.1.6  Thawing mouse embryonic stem cells  
Prior to thawing, 15 mL falcon tubes were labeled and filled with 10 mL of pre-warmed 
ES complete media (~ 37 °C). Pre-prepared gelatin coated plates were aspirated and air 
dried in the laminar air flow hood. Cryo-vials were transported on dry ice from liquid 
nitrogen storage to the tissue culture room. Cryo-vials were placed in 37 °C water bath 
untill a small core of frozen cell solution remained. 1 mL of pre-warmed ES complete 
media (~ 37 °C) was added to the vial and the cell suspension was transferred to a 15 mL 
falcon tube. The falcon was closed and inverted multiple times to dilute the DMSO. The 
tube was spun down (5 min, 500 rpm, RT), the supernatant was aspirated and the cell 
pellet resuspended in 2 mL of pre-warmed ES complete media. Cell suspension was 
plated in a 6 well plate which was incubated at 37 °C with 5 % CO2 in a humidified 
incubator. 
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6.1.7  Counting ES cells using the Neubauer chamber 
Single cell suspension was generated as described previously. 50 µL of the cell 
suspension was diluted in 50 µL of 0,4 % (w/v) Trypan blue (Invitrogen, 15250). 
Neubauer improved chamber was mounted according to manufacturer recommendations 
and 10 µL of the cell dilution was loaded onto the chamber (Neubauer improved, depth: 
0,1 mm, 0,0025 mm2). The chamber was placed on an inverted DM IL LED microscope 
from Leica with an HI PLAN 10x/0,22 PH1 objective. Both, live cells (transparent) and 
dead cells (blue) were counted according to manufacturer recommendations in all grey 
shaded groups squares (one group square consist of 16 single squares) (Figure 29).  
 
Figure 29: Counting grid of a Neubauer improved chamber.  
Cells alive (transparent) and dead (blue) were counted within the grey indicated areas of the 
grid. One group quadrat consists of 16 smaller quadrats. The sum of all cells was counted in 
all four group quadrats according to manufacturer recommendations. 
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The final cell concentration was calculated as follows: 
 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 = ∑𝑁𝑢𝑚𝑏𝑒𝑟	𝑜𝑓	𝑐𝑒𝑙𝑙𝑠 	𝑥	10,000	𝑥	𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛Q.)(*+𝑁R+*ST	US.V+.(W 				X𝑐𝑒𝑙𝑙𝑠𝑚𝐿 Z 
 
Cell viability was calculated as follows: 
 𝑉𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 = ∑ 𝑙𝑖𝑣𝑒	𝑐𝑒𝑙𝑙𝑠∑ 𝑎𝑙𝑙	𝑐𝑒𝑙𝑙𝑠	(𝑙𝑖𝑣𝑒	𝑐𝑒𝑙𝑙𝑠 + 𝑑𝑒𝑎𝑑	𝑐𝑒𝑙𝑙𝑠) 	𝑥	100			[%] 
 
 
6.2  Genetic modification of mESCs 
6.2.1  Generation of stable transgenic miRNA reporter cell lines  
The day prior to transfection, Ab2.2 wild type cells were seeded on gelatin coated plates 
(10 cm dish from Nunc) in ES complete media using a seeding cell number resulting in 
60 - 80 % of confluency on the day of transfection (seed ~	1.000.000 cells per 10 cm 
dish (Nunc)). Seeded cells were incubated overnight at 37 °C with 5 % CO2 in a 
humidified incubator. The next day, culture media was replaced 2 hours prior to 
transfection. 25 µg of the target DNA was diluted in 1,2 mL OpiMEM. DNA dilution was 
mixed and 75 µL of FuGene (Promega, E2312, aquilibrated at RT) was added to the mix. 
The solution was mixed by pipetting and incubated for 15 min at RT without additional 
mixing. The transfection mix was added to the cells in dropwise manner using a 1 mL 
Gilson pipette. The transfected plate was incubated at 37 °C with 5 % CO2 in a humidified 
incubator, overnight.  
All plasmids used to generate transgenic miRNA reporter lines included a 
Hygromycin antibiotic selection cassette (PGK::HygroR-bGHpA). On the day after 
transfection, ES complete media was replaced by Hygromycin selection media (ES 
complete + 100 µg/mL Hygromycin B (Invitrogen, ant-hg-5)). The selection media 
volume was chosen according to the culture plate used. Selection media was changed on 
a daily basis after washing cells with D-PBS in order to remove dead cells. Seven days 
after selection, isolated single colonies were visible using an inverted DM IL LED 
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microscope (Leica). Selection media was replaced by D-PBS after washing the plate 
twice with D-PBS (RT). Colonies were checked for equal expression of Citrine and 
mCherry in all cells of a given colony, using the inverted DM IL LED microscope (Leica). 
Positive colonies were dislodged using a pipet tip and aspirated in 20 µL PBS. The colony 
was transferred to a 96 well v-bottom plate. Having picked 96 colonies per construct, 
20 µL of 0,05 % Trypsin-EDTA solution (Invitrogen, 25300) was added to the wells 
using a multichannel pipet. The plate was incubated for 5 min in a humidified incubator 
(37 °C, 5 % CO2). Cells were rescued by addition of 200 µL Hygromycin selection media 
(ES complete + 100 µg/mL Hygromycin B (Invivogen, ant-hg-5)). Each well was 
resuspended 8 - 10 times using a multichannel pipette, in order to generate single cell 
suspension. The entire volume was transferred to a pre-prepared gelatin coated 96 well 
plate and incubated at 37 °C with 5 % CO2 in a humidified incubator. After three days 
(daily media change), 96 well plates were duplicated and daughter plates were measured 
on an HTS BD LSRFortessa™ flow cytometry analyzer, to identify clones expressing 
equal levels of both, Citrine and mCherry fluorescent reporter. Positive clones were 
expanded and frozen.  
6.2.2  Generation of miRNA+ /-  and miRNA - / -  KO cell lines  
Heterozygous and homozygous miRNA KO cell lines were generated using the 
CRISPR/Cas9 gene editing approach. For each miRNA KO cell line a specific single 
guide RNA (sgRNA) was designed using the improved CRISPR sgRNA design website 
(Xu et al. 2015). The resulting sgRNA was cloned into the pX330-U6-Chimeric-BB-
CBh-hSpCas9 backbone following Hsu et al. (2013). The resulting construct was 
cotransfected with a plasmid encoding puromycin resistance into the respective miRNA 
reporter cell line using FuGene transfection reagent. The day after transfection, 
puromycin selection media (ES complete + 1 µM puromycin) was applied to the cells. 
Selection media was changed on a daily basis after washing cells with D-PBS (RT) in 
order to remove dead cells. Cells were re-plated in a new gelatin coated 6 well dish after 
2 days of puromycin selection and incubated for additional 2 days in puromycin selection 
media. Successfully edited clones were identified via miRNA reporter derepression and 
single cell sorted in 96 well plates using BD FACSAria™Fusion flow cytometer. Clones 
not showing a fluorescent reporter derepression were still single cell sorted since the 
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respective miRNA might not be expressed in pluripotent state. miRNA+/- and miRNA-/- 
deletions were confirmed by sequencing of genomic PCR products. 
6.2.3  Generation of stable transgenic fate marker cell lines  
The homology recombination approach was used to generate stable transgenic fate 
marker cell lines for all three major germ layers i) endoderm (Sox17) ii) mesoderm 
(Vimentin) and iii) neuroectoderm (Tuj1). The Ab2.2 mESC genome was edited as such 
that one allele of the respective endogenous fate marker was replaced by an H2B-Citrine 
fluorescent reporter. The fluorescent reporter additionally harbored an FRT flanked G418 
antibiotic resistance cassette in order to select for successfully edited clones. The entire 
construct was placed under the endogenous promoter of the respective fate marker gene. 
Bacterial artificial chromosomes (BAC) of each fate marker were used to PCR-amplify 
DNA fragments encoding homology arms. The MXS-chaining technique (Sladitschek 
and Neveu 2015a) and subsequent homology recombination within the corresponding 
BAC was used to generate a final plasmid encoding the H2B-Citrine fluorescent reporter 
flanked by 5 prime (~ 2 kb) and 3 prime (~ 8 kb) homology arms. Prior to transfection, 
the final construct was linearized with an AsiSI-enzyme (overnight) restriction digest in 
order to cut within the vector backbone, but not the insert. 25 µg of the target plasmid 
DNA was digested using 15 U of AsiSI enzyme in a total reaction volume of 50 µL 
(37 °C, overnight). Completion of the restriction digest was checked by analyzing 1/50 
of the restriction digest on an analytical agarose gel (1 % (w/v) agarose in TAE buffer). 
The restriction digest was heat-inactivated for 20 min at 80 °C. The entire volume of the 
restriction digest was used for a FuGene transfection of Ab2.2 cells (section 5.2.1). The 
day after transfection, ES complete media was replaced by G418 selection media (ES 
complete + 1 mg/mL G418). Selection media was changed on a daily basis after washing 
cells with D-PBS (RT), in order to remove dead cells. Seven days after selection, single 
colonies were visible and dislodged as described in section 5.2.1. Cells were kept on 
96 well plates in G418 selection media for additional 3 days. 96 well plates were 
duplicated and the mother plate was kept in G418 selection media (split every other day), 
while the daughter plate was seeded for a 6-day differentiation experiment towards the 
respective cell fate (section 5.3). Successfully edited clones were identified after 6 days 
of differentiation using the BD FACSAria™Fusion flow cytometer, measuring H2B-
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Citrine expression levels. The correct reporter insertion was confirmed by genomic PCR 
products and southern blot. Thereafter, the FRT flanked selection cassette was removed 
by flipase transfection. After 4 days of flipase treatment, cells were single cell sorted into 
96 well plates. Successful removal of the selection cassette was validated by duplicating 
the respective 96 well plates into mother and daughter plates. The mother plate was kept 
in ES complete media whereas the daughter plate was cultured in G418 selection media 
for three days. Clones negative for the selection cassette died upon G418 treatment. The 
corresponding mother clone, was enlarged and frozen as described in section 5.1.5. 
6.2.4  Genomic DNA extraction 
Cells were grown to ~ 80 % confluency on 12 well plates. Cells were harvested and 
transferred to a 1.5 mL Eppendorf tube. Cells were spun down (2 min, 4000 rpm) and the 
supernatant was removed. The cell pellet was covered (not mixed) with 200 µL spooling 
buffer (75 mM NaCl, 25 mM EDTA, 1 % SDS) containing 1 µL fresh Proteinase K and 
incubated at 55 °C, overnight (without shaking). The following day, 50 µL Brine (NaCl 
< 5 M) was added to the sample, and the sample was inverted several times during an 
incubation period of 5 min at 55 °C. After addition of 250 µL 2-propanol, the sample was 
again inverted and spun down (10 min, max speed, RT). The supernatant was removed 
and the pellet washed with 70 % Ethanol. The sample was spun down (10 min, max 
speed, RT), the supernatant removed and the cell pellet air dried at 55 °C. The resulting 
DNA was solubilized by addition of 200 µL EB buffer (shaking in the thermomixer, 
55 °C). Samples were stored at (- 20 °C). 
 
6.3  Differentiation of mESCs 
6.3.1  Differentiation towards the endoderm germ layer  
AB2.2 cells were differentiated towards endoderm progenitors following Borowiak et al. 
(2009). Cells were seeded on gelatin coated plates ~ 16 hours before starting 
differentiation with a seeding density of 5000 cells/cm2 in ES complete media. Cells were 
incubated in a humidified incubator (37 °C, 5 % CO2), overnight. Next day, cells were 
washed with D-PBS (RT) twice, before adding pre-warmed (~ 37 °C) IDE differentiation 
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media (Table 4) to the cells. Cells were incubated at 37 °C and 5 % CO2 in a humidified 
incubator. Differentiation media was changed on a daily basis from day 2 of 
differentiation, with prior washes of D-PBS (RT) in order to remove dead cells. 
Table 4: IDE1 - media composi tion. 
Component Comment Supplier (Number) Concentration 
Advanced RPMI w/o HEPES, 
w/o L-Glutamine 
Invitrogen (12633) 98 % (v/v) 
Fetal Bovine Serum ES-qualified Millipore (ES-009-B) 0,2 % (v/v) 
100x L-Glutamine 200 mM Invitrogen (25030) 1x (2 mM) 
100x Penicillin- 
        Streptomycin 
10,000U mL-1 
10,000U mL-1 
Invitrogen (15140) 1x (100 U/mL 
Pen./Strep.) 
IDE1 inducer of definitive 
endoderm 
Tocris Bioscience (4015) 1 µM 
 
6.3.2  Differentiation towards the mesoderm germ layer  
AB2.2 cells were differentiated towards mesoderm progenitors following Torres et al., 
(2012). Cells were seeded on gelatin coated plates ~ 16 hours before starting mESC 
differentiation with a seeding density of 5000 cells/cm2 in ES complete media. Cells were 
incubated at 37 °C with 5 % CO2 in a humidified incubator, overnight. The next day, cells 
were washed with D-PBS (RT) twice, before adding pre-warmed (~ 37 °C) GMEM 
differentiation media (Table 5). Cells were incubated at 37 °C with 5 % CO2 in a 
humidified incubator. The differentiation media was changed from day 2 of 
differentiation every day, with prior washes of D-PBS in order to remove dead cells. 
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Table 5: GMEM - media composition.  
Component Comment Supplier (Number) Concentration 
GMEM BHK 21  Invitrogen (21710) 96 % (v/v) 
KSR  Invitrogen (10828) 10 % (v/v) 
100x Non-Essential 
        Amino Acids 
10 mM glycine 
10 mM L-alanine 
10 mM L-asparagine 
10 mM L-aspartic acid 
10 mM L-glutamic acid 
10 mM L-proline 
10 mM L-serine 
Invitrogen (11140) 1x (100 µM) 
100x Sodium Pyruvate 100 mM Invitrogen (11360) 1x (100 µM) 
100x Penicillin- 
        Streptomycin 
10,000U mL-1  
10,000U mL-1 
Invitrogen (15140) 1x (100 U/mL 
Pen./Strep.) 
2-Mercaptoethanol 55 mM in D-PBS Invitrogen (21985) 100 µM 
 
6.3.3  Differentiation towards the ectoderm germ layer  
AB2.2 cells were differentiated towards neuroectoderm progenitors following Ying et al., 
(2003). Cells were seeded on gelatin coated plates ~ 16 hours before starting 
differentiation with a seeding density of 15000 cells/cm2 in ES complete media. Cells 
were incubated overnight in a humidified incubator with 5 % CO2 at 37 °C. The next day, 
cells were washed with D-PBS (RT) twice, before adding pre-warmed (~ 37 °C) N2B27 
differentiation media (Table 6). Cells were incubated in a humidified incubator with 
5 % CO2 at 37 °C. The differentiation media was changed from day 2 of differentiation 
every day with prior washes using D-PBS in order to remove dead cells. 
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Table 6: N2B27 - media composition.  
Component Comment Supplier (Number) Concentration 
Neurobasal medium w/o L-Glutamine Invitrogen (21103) 48,4 % (v/v) 
DMEM/F12 1x w/o HEPES 
with L-Glutamine 
Invitrogen (21041) 48,4 % (v/v) 
100x L-Glutamine 200 mM Invitrogen (25030) 0,25 mM 
100x Penicillin- 
        Streptomycin 
10,000U mL-1 
10,000U mL-1 
Invitrogen (15140) 1x (100 U/mL 
Pen./Strep.) 
B27 Supplement 50x with vitamin A Invitrogen (17504) 0,5 x 
N2 Supplement 100x 1mM transferrin 
86 µM insulin 
2 µM progesterone 
10 mM putrescine 
10 µM selenite 
Invitrogen (17502) 0,48 % (v/v) 
BSA fraction V for mouse  
embryo culture  
SIGMA (A3311) 10 µg/mL 
Insulin (human) recombinant SIGMA (91077C) 10 µg/mL 
Retinoic Acid inducer of ectoderm SIGMA (R2625) 1 µM 
 
6.4  Immunofluorescence 
Cells were harvested and counted as described previously. Cells were seeded on gelatin 
coated 8 well µ-slides (ibidi) in ES-complete media with various seeding densities, 
depending on the experiment performed (pluripotent state, endoderm and mesoderm 
differentiation: 5000 – 10,000 cells/cm2; neuroectoderm differentiation: 15.000 – 20.000 
cells/cm2). Cells were washed with D-PBS (RT), 12 to 16 hours after seeding and prior 
to addition of the corresponding differentiation media. Cells were differentiated for 
6 days as described in section 5.3. On the final day of differentiation, cells were washed 
twice with D-PBS (RT), to remove debris and dead cells. Cells were fixed with 200 µL 
of 4 % PFA (4 % v/v PFA (16 %) in D-PBS, pH 7,4) (30 min, RT). PFA was quenched 
by addition of 200 µL glycine (300 mM glycine in D-PBS, pH 7,4) (1 h, RT). The fixative 
mix was aspirated and the entire plate gently washed (2x) in a beaker containing 400 mL 
TNT buffer (100 mM Tris-Cl, pH 8,0; 150 mM NaCl; 0,1 % v/v Tween-20). TNT buffer 
was aspirated and cells covered in 200 µL AB-buffer (0,01 % (w/v) BSA; 0,2 % (w/v) 
SDS; 1 % (v/v) Triton X 100), for permeabilization (1 h, RT). AB buffer was removed 
and cells overlaid with blocking buffer (5 % (w/v) BSA) for 1 h (RT). After blocking, 
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primary AB was diluted in blocking buffer (Table 7) and incubated overnight at 4 °C 
in a humidity chamber (prevents air drying of primary AB solution). Primary antibodies 
from different species targeting the same sample, were incubated in one reaction mix, 
overnight. 
Table 7: Primary antibodies for immunostaining. 
Antibody Source Supplier (Number) Dilution 
Oct 3/4 mouse mAb Santa Cruz (sc-5279) 1:250 
Nanog rabbit pAb Bethyl (A300-397A) 1:250 
FoxA2 rabbit mAb Cell Signaling (8186) 1:400 
Desmin Rabbit mAb Cell Signaling (5332)) 1:100 𝜶SMA mouse mAb SIGMA (A2547) 1:800 
Vimentin rabbit mAb Cell Signaling (5741) 1:200 
Tuj1 (𝜷-III-tubulin) rabbit mAb Cell Signaling (5568) 1:200 
 
Slides were washed twice in a large volume of TNT buffer (400 mL, 5 min, RT), before 
adding fluorescently labeled secondary antibody, diluted in AB buffer (Table 8). Slides 
were incubated in the dark for 2 h (RT).  
Table 8: Secondary antibodies for immunostaining.  
Antibody Source Supplier (Number) Dilution 
anti-mouse goat IgG, F(ab’)2 fragment 
labeled with Pacific Blue (405) 
Invitrogen (P31581) 1:2000 
anti-rabbit goat IgG, F(ab’)2 fragment 
labeled with Alexa Flour 647 
Cell Signaling (4414) 1:1000 
 
Slides were washed twice in a large volume of TNT buffer (400 mL, 5 min, RT). All 
liquid was carefully removed and cells overlaid with fresh TNT buffer. Confocal imaging 
was performed on an inverted SP8 confocal microscope with a 40x PL Apo 1,1 W 
objective 8 (Leica). 
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6.5  Live cell imaging of miRNA reporter cell lines 
Reporter cell lines were seeded on gelatin coated 8 well µ-slides (ibidi) with a seeding 
density of 5000 – 10,000 cells/cm2. Cells were cultured up to three days in ES-complete 
(daily media change). The specimen was mounted onto an inverted SP8 confocal 
microscope with a 40x PL Apo 1,1 W objective 8 (Leica). Cells were imaged within the 
humidified incubation chamber at 37 °C and 5 % CO2. The fluorescent reporters Citrine 
and m-Cherry were excited using 514 nm and 561 nm lasers, respectively. The emitted 
signals were acquired sequentially using HyD detectors and line or frame averaging in 
order to reduce imaging noise. Captured images were analyzed using ImageJ (Fiji). 
 
6.6  Flow Cytometry Analysis and Single Cell Sorting 
6.6.1  Flow Cytometry Analysis using LSRFortessa™ Analyzer  
Samples from 96 well plates: 
Samples from 96 well plates were washed with 200 µL D-PBS (RT), dislodged by 
addition of 25 µL 0,05 % Trypsin-EDTA (Invitrogen) per well and incubated for 4 min 
at 37 °C in a humidified incubator. Cells were rescued by addition of 200 µL ES-
complete. Single cell solution was achieved by resuspending the cell solution 8 - 10 
times. The volume was transferred to a fresh 96 well v-bottom plate. Plates were mounted 
onto the BD™ HTS plate reader, according to manufacturer recommendation without 
prior filtration of the samples. 
Samples from any other culture dish but 96 well plates: 
Cells were washed with D-PBS prior to addition of 0,05 % Trypsin-EDTA (Invitrogen) 
(volume according to plate size) and subsequent incubation for 4 min at 37 °C in a 
humidified incubator. Cells were rescued by addition of ES complete media. Cells were 
resuspended 8 - 10 times for single cell solution. Cells were spun down (2500 rpm, 2 min, 
RT or 500 rpm, 5 min, RT) and the supernatant was discarded. The cell pellet was 
resuspended in a minimum of 200 µL D-PBS (RT) or more, depending on the cell pellet 
size. Cells were resuspended 8 - 10 times for single cell solution and filtrated through a 
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40 µm cell strainer (BD Biosciences) into a polystyrene flow tube (Falcon, 352058). The 
sample was measured according to manufacturer recommendations. 
Data acquisition and analysis: 
The total cell number acquired varied between experiments. For a standard experiment 
2 x 105 – 1 x 106 live single cells were recorded. Cells were analyzed using the FlowJo 
software. In order to gate live from dead cells, side-scatter area over forward scatter area 
was plotted. The resulting sub-population was plotted using side-scatter area over side-
scatter width, which discriminated single-cells from doublets. The single cell population 
was plotted using the corresponding fluorescent colors in question. In case of miRNA-
activity measurements, the fluorescent color values were exported using the .fcs file. The 
ratio of fluorescent normalizer (mCherry) over fluorescent detector (Citrine) was 
calculated. The resulting single cell values were plotted as a distribution function for 
every condition, using a customized Python script. 
6.6.2  Single Cell Sorting using BD FACS Melody and Aria 
Gelatin coated flat bottom 96 well plates were prepared containing 150 µL ES-complete 
media on the day of sorting. Cells were harvested as described earlier. Cell pellet was 
resuspended in 1 - 2 mL D-PBS (RT) and filtered through a 40 µm cell strainer into a 
polypropylene flow tube (BD Falcon, 352063). 10,000 cells were acquired prior to 
sorting. The target population to be sorted was gated with this preliminary acquisition. 
Single cells were sorted in purity mode, with one cell per well. Sorted 96 well plates were 
incubated for 7 days at 37 °C and 5 % CO2 in a humidified incubator. 
 
6.7  Molecular biology techniques 
6.7.1  Kits, Buffers and Solutions  
All DNA constructs for this thesis project were generated following the MXS-chaining 
technique (Sladitschek and Neveu 2015a). DNA purification kits were used for 
purification of small-scale-plasmid DNA (QIAprep Spin Miniprep Kit) and large-scale 
plasmid DNA (Qiagen Plasmid Plus Midi Kit) according to manufacturer 
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recommendations. Cloned plasmids were validated by analytical restriction digest and 
sanger sequencing (Eurofins GATC Biotech). All buffers and solutions used for cloning 
DNA constructs are listed below. 
TAE-Buffer: 40 mM Tris-acetate, 1 mM EDTA, pH 8,3 
LB media: 1 % w/v Tryptone, 0,5 % w/v Yeast Extract, 1 % NaCl, pH 7,0 
SOB media: 2 % w/v Tryptone, 0,5 % w/v Yeast Extract, 10 mM NaCl, 2,5 mM KCL, 
10 mM MgSO4 
SOC media: 2 % w/v Tryptone, 0,5 % w/v Yeast Extract, 10 mM NaCl, 2,5 mM KCL, 
10 mM MgSO4, 20 mM glucose, pH 6,8 
YENB media: 0,75 % w/v Bacto Yeast Extract, 0,8 % w/v Nutrient Broth, pH 7,5 
YT media: 1,6 % w/v Tryptone, 1 % w/v Yeast Extract, 0,5 % NaCl, pH 7,0 
LB agar plates & antibiotics: LB media was supplemented with 1,5 % w/v agar, 
autoclaved and prepared as plates. Heat sensitive antibiotics were added to the solution 
shortly before pouring the plates. Ampicillin (100 µg/mL, SIGMA) selection was used 
for the standard cloning. BAC engineering was carried out using the following antibiotics 
and concentrations (Table 9). 
Table 9: Antibiotics for cloning, media and plates.  
Antibiotic Stock solution Concentration 
liquid media 
Concentration 
LB plates 
Chloramphenicol 34 mg/mL 10 µg/mL 15 µg/mL 
Tetracycline 5 mg/mL 5 µg/mL) 5 µg/mL 
Kanamycin 30 mg/mL 10 µg/mL 15 µg/mL 
Ampicillin 100 mg/mL 50 µg/mL 100 µg/mL 
 
6.7.2  PCR reactions  
PCR primers and primer pairs were designed as such that the predicted melting 
temperature (TM) reached ~ 59 °C + 1,5 °C. Primers and primer pairs were checked for 
secondary structure formation and heterodimer formation using cloning software 
“Geneious” and the online “oligo analyzer tool” (idtdna.com). Primers were ordered from 
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SIGMA as desalted, lyophilized oligonucleotides. Primers were reconstituted in EB-
buffer according to manufacturers recommendations. Standard PCR reactions were 
performed using Physion High Fidelity DNA polymerase (Thermo Scientific). The 
standard PCR reaction was set up as follows (Table 10).  
Table 10: Standard PCR reaction mix.  
Component 1x [µL] 
H2O fill to 25 
5x GC buffer 5 
DMSO 0,75 
DNTP mix 0,5 
Primer forward 0,25 (500 nM) 
Primer reverse 0,25 (500 nM) 
DNA ≤ 250 ng 50 – 100 ng 
Phusion 0,2 (0,5U) 
Primer reverse 0,25 
 
Nuclease free water was added first to the reaction tube in order to dilute small volume 
components. Physion DNA Polymerase was added last to the reaction mix. The PCR 
reaction was performed in a thermocycler (Bio-Rad, S-1000) using the following PCR 
program (Table 11). 
Table 11: Standard PCR program.  
Step Temp [°C] Duration Repeats 
Initial denaturation 98 2 min 1 
Denaturation 
Annealing 
Extension 
98 
TM + 1,5 
72 
20 sec 
20 sec 
30 sec / kb 
39 
Final extension 72 2 min 1 
End 4 ∞ NA 
 
The number of PCR cycles was decreased for BAC engineering (25 cycles). PCR 
products were gel purified using a 0,8 % Agarose (SIGMA) gel. Purified DNA products 
were excised from the gel and extracted using the QIAquick Gel Extraction Kit (Qiagen) 
according to manufacturer recommendations. 
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6.7.3  Restriction digest  
Restriction digest was carried out using NEB reaction enzymes and corresponding buffers 
according to manufacturer’s recommendations. The appropriate reaction conditions and 
correct combination of restriction enzymes was planned using the NEBcloner® 
(nebcloner.neb.com). The standard restriction digest was set up as follows (Table 12). 
Table 12: Standard Restrict ion digest.  
Component Concentration 
DNA 2 - 4 µg 
Restriction enzyme buffer 1x 
H2O fill to 30 µL 
Restriction enzyme 5 U 
 
The amount of DNA and reaction volume varied depending on the needs of the cloning 
experiment. The restriction digest was incubated either for 1 h at 37 °C or overnight in 
case of BAC engineering. Restriction digest products were gel purified using a 0,8 % 
Agarose (SIGMA) gel. Purified DNA products were excised from the gel and extracted 
using the QIAquick Gel Extraction Kit (Qiagen). 
6.7.4  Ligation  
The Ligation mix was prepared in an 1,5 mL Eppendorf tube where the T4 Ligase was 
added last. The Ligation (Table 13) was mixed and incubated for 15 min at RT and 
target DNA was transformed as described in section 5.7.6. 
Table 13: Standard Ligation mix.  
Component Volume [µL] 
DNA (backbone) 1 
DNA (insert) 6 
T4 DNA ligase buffer 1 
H2O 8 
T4 DNA ligase 0,3 
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6.7.5  Preparation of chemically competent bacteria  
Chemically competent Mach T1® bacteria were generated using the calcium-manganese 
based (CCMB) method (Hanahan, Jessee, and Bloom 1991). All glassware was filled 
with deionized water and autoclaved prior to growing cells in order to remove detergent 
residues. Detergent is the major inhibitor of competent cell growth and transformation 
efficiency. 
 One vial of Mach T1® competent bacteria seed stock was thawed (RT), 
transferred to an Erlenmeyer containing 100 mL of SOB media and incubated overnight 
(30 °C, shaking). 10 mL of the overnight culture was inoculated in 1 L SOB media and 
incubated (30 °C, shaking) till the OD600 reached 0,3. Bacteria were spun down 
(3000 rpm, 10 min, 4 °C) and the supernatant discarded. The bacteria pellet was 
resuspended in 80 mL of ice cold CCMB80 buffer. Suspension was stored for 20 min on 
ice, spun down (3000 rpm, 10 min, 4 °C) and the supernatant discarded. The pellet was 
again resuspended in ice cold CCMB80 till the OD600 matched a value of 1,0 – 1,5. 
Bacteria were aliquoted in Eppendorf tubes (150 µL reactions) and flash frozen in liquid 
nitrogen. Bacteria were stored in - 80 °C. 
6.7.6  Transformation of chemically competent bacteria  
During incubation of the ligation mix, Mach T1® competent bacteria were thawed on ice. 
10 µL of the ligation mix was transferred to a fresh Eppendorf tube and chilled on ice for 
5 min. 100 µL of competent bacteria were added to the ligation mix. The tube was flicked 
and incubated for 10 min on ice. Bacteria were transformed by incubation of the reaction 
mix in a prewarmed ThermoMixer® (Eppendorf) (1 min, 42 °C). Subsequently, bacteria 
were chilled on ice for 5 min. Bacteria were spun down (8000 rpm, 30 sec), the 
supernatant was removed, the pellet was resuspended in 50 µL LB media and 
subsequently plated on LB agar plates containing the respective antibiotic for selection. 
Transformed bacteria with ligation products > 10 kb, were allowed to recover (60 min, 
37 °C, shaking 300 rpm) in 1,5 mL SOC media before plating.  
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6.7.7  BAC engineering  
Fluorescent fate marker cell lines are based on DNA plasmids generated by BAC 
engineering. Bacterial artificial chromosome containing the respective fate marker for 
endoderm (Sox17), mesoderm (Vimentin) and neuroectoderm (Tuj1) were identified 
using PubMed and Ensembl. BACs were ordered from Source Bioscience and served as 
template to PCR-amplify DNA fragments encoding small homology arms. DNA plasmids 
were generated following the MXS-chaining technique (Sladitschek and Neveu 2015a). 
The intermediate construct was set up as such, that the H2B-Citrine fluorescent reporter 
and G418 selection cassette was flanked by small homology arms (~ 200 bp – 500 bp). 
For homology recombination of the respective BAC, bacteria were electroporated as 
described in section 5.7.8. The final plasmid was achieved by retrieving the H2B-Citrine 
fluorescent reporter flanked by the respective 5 prime (~ 2 kb) and 3 prime (~ 8 kb) 
homology arms. High purity plasmid DNA for transfection of embryonic stem cells was 
purified using the Qiagen Plasmid Plus Midi Kit. 
6.7.8  Electroporation of bacteria  
Bacteria were electroporated using the Bio-Rad Gene Pulser® electroporation system. 
Glycerol stock of the respective bacteria was inoculated the day before electroporation 
and grown overnight in the respective culture media supplemented with the right 
antibiotics (37 °C, shaking 300 rpm). 80 µL of the overnight culture was inoculated in 
2 mL fresh media and incubated for 2 h at 37 °C (shaking 300 rpm). 1 mL of culture was 
transferred to a precooled reaction tube and spun down (30 sec, 8000 rpm, 4 °C. 
Supernatant was removed and the pellet resuspended in 1 mL of ice-cold glycerol (10 % 
(v/v) glycerol in sterile water). Bacteria were spun down (30 sec, 8000 rpm, 4 °C), the 
supernatant was removed and the bacteria pellet was resuspended in the corresponding 
ice-cold DNA mix (500 ng restriction digested and gel purified plasmid DNA in a total 
of 100 µL water). The solution was transferred to a chilled electroporation cuvette 
(without air bubbles) on ice. Bacteria were electroporated (1,8 kV; 25 µF; 200 Ω) 
according to manufacturer recommendations. Bacteria were rescued in 1 mL pre-warmed 
(~ 37 °C) SOC media and transferred to an Eppendorf tube. Bacteria were recovered for 
60 min at 37 °C (shaking 300 rpm). After recovery, bacteria were spun down (30 sec, 
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8000 rpm) and the supernatant was removed. The bacteria pellet was resuspended in 
50 µL LB media and plated onto LB Agar plates containing the respective antibiotics. 
Plates were incubated overnight at 37 °C. The next day a single colony was picked, 
inoculated in 2 mL media containing the appropriate antibiotics and prepped ~ 6 h after 
inoculation. 
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